US20130189334A1 - Enhancing properties by the use of nanoparticles - Google Patents
Enhancing properties by the use of nanoparticles Download PDFInfo
- Publication number
- US20130189334A1 US20130189334A1 US13/792,478 US201313792478A US2013189334A1 US 20130189334 A1 US20130189334 A1 US 20130189334A1 US 201313792478 A US201313792478 A US 201313792478A US 2013189334 A1 US2013189334 A1 US 2013189334A1
- Authority
- US
- United States
- Prior art keywords
- silver
- nanoparticles
- laponite
- composite material
- metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
- A01N25/28—Microcapsules or nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0245—Specific shapes or structures not provided for by any of the groups of A61K8/0241
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D1/00—Coating compositions, e.g. paints, varnishes or lacquers, based on inorganic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
- A61F2013/8408—Additives, e.g. for odour, disinfectant or pH control with odour control
- A61F2013/8426—Additives, e.g. for odour, disinfectant or pH control with odour control with metallic salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/62—Coated
- A61K2800/621—Coated by inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/624—Nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
Definitions
- the present invention relates to composite materials that are functionalized nanoparticles and in particular, metal-loaded nanoclays. Additionally, the present invention relates to a method of forming such composite materials.
- silver metal has been known to be an agent capable of killing many different microbial species. It was commonly used to purify drinking solutions or administered to sick individuals before the existence of modern antibiotics. Even after the discovery of penicillin and its descendents, colloidal silver solutions were often used in cases in which troublesome bacteria had become resistant to antibiotics.
- Colloidal silver solutions are commercially available today. They are often unstable, however, and have a short shelf life. This is due to the tendency of the silver particles to aggregate and form clusters so large that they are no longer suspended in solution. For this reason, undesirable gelling agents are added to solutions to keep the silver particles suspended by preventing particle aggregation.
- Another problem of the commercially available solutions is that the majority of the silver content is usually found to be silver ions. This poses a large problem in medical applications where silver ions rapidly combine with ubiquitous chloride to form an insoluble white precipitate.
- Nanoparticles have been known to be used as fillers as disclosed in U.S. Pat. No. 6,492,453, as coatings as disclosed in US 2003/0185964 and as foam components as disclosed in U.S. Pat. No. 6,518,324.
- Nanoparticle systems are disclosed in US 2002/0150678 as being used in a composition and a method to impart surface modifying benefits to soft and hard surfaces.
- this application discloses a soft surface coating for articles such as fabrics and garments.
- Inorganic particulates such as, clays, silicates, and alumina have been widely used in combination with adjunct detergent and laundry compounds to impart some form of antistatic control and/or fabric softening benefit.
- the present invention relates to composite materials comprising metal loaded onto exfoliated nanoparticles.
- Such functionalized nanoparticles may be incorporated into solid and liquid materials to enhance or modify their bulk physical and performance characteristics.
- the metal is silver and the nanoparticle comprises a nanoclay.
- Silver ion is reduced to its neutral metal state) (Ag 0 ) and loaded onto the nanoclay.
- Silver-coated nanoclays in particular have excellent antimicrobial properties, and represent a less expensive alternative to the use of colloidal silver solutions.
- Such nanoparticles made according to the invention are stable and use less silver metal to generate the same surface area as solid silver particles, making them more cost efficient.
- the invention provides a composite material comprising (a) an exfoliated nanoparticle having a surface and (b) a metal selected from Groups 3 to 12, aluminum and magnesium, wherein the metal is loaded onto the surface of the nanoparticle.
- the invention also provides a method of making a composite material comprising an exfoliated nanoparticle having a metal coating, which method comprises: (a) reducing a metal ion to metal; (b) exfoliating a starting material to form a nanoparticle; and (c) contacting the metal with the exfoliated nanoparticle, whereby steps (a) and (b) may be performed sequentially in any order or simultaneously and the metal is loaded onto the surface of the exfoliated nanoparticle.
- the invention further provides solutions, solids, gels, coating compositions, cosmetic and pharmaceutical compositions, and articles of manufacture comprising such a composite material.
- FIG. 1 shows the particle size distribution of the material of Example 1.
- FIG. 2 shows the particle size distribution of the material of Example 5.
- FIG. 3 shows the particle size distribution of the material of Example 6.
- FIG. 4 shows the particle size distribution of the material of Example 7.
- Every limit given throughout this specification includes every lower or higher limit, as the case may be, as if such lower or higher limit was expressly written herein. Every range given throughout this specification includes every narrower range that falls within such broader range, as if such narrower ranges were all expressly written herein.
- Nanoparticles as used herein means particles (including but not limited to rod-shaped particles, disc-shaped particles, platelet-shaped particles, tetrahedral-shaped particles), fibers, nanotubes, or any other materials having dimensions on the nano scale.
- the nanoparticles have an average particle size of about 1 to about 1000 nanometers, preferably 2 to about 750 nanometers. That is, the nanoparticles have a largest dimension (e.g., a diameter or length) of about 1 to 1000 nm.
- Nanotubes can include structures up to 1 centimeter long, alternatively with a particle size from about 2 to about 50 nanometers. Nanoparticles have very high surface-to-volume ratios.
- the nanoparticles may be crystalline or amorphous.
- a single type of nanoparticle may be used, or mixtures of different types of nanoparticles may be used. If a mixture of nanoparticles is used they may be homogeneously or non-homogeneously distributed in the composite material or a system or composition containing the composite material.
- Non-limiting examples of suitable particle size distributions of nanoparticles are those within the range of about 2 nm to less than about 750 nm, alternatively from about 2 nm to less than about 200 nm, and alternatively from about 2 nm to less than about 150 nm. It should also be understood that certain particle size distributions may be useful to provide certain benefits, and other ranges of particle size distributions may be useful to provide other benefits (for instance, color enhancement requires a different particle size range than the other properties).
- the average particle size of a batch of nanoparticles may differ from the particle size distribution of those nanoparticles.
- a layered synthetic silicate can have an average particle size of about 25 nanometers while its particle size distribution can generally vary between about 10 nm to about 40 nm. It should be understood that the particle size distributions described herein are for nanoparticles when they are dispersed in an aqueous medium and the average particle size is based on the mean of the particle size distribution.
- the nanoparticles are exfoliated.
- a starting material is exfoliated or disbursed to form the nanoparticles.
- Such starting material may have an average size of up to about 50 microns (50,000 nanometers).
- the nanoparticle may comprise for example natural or synthetic nanoclays, including those made from amorphous or structured clays.
- the exfoliated nanoparticle is a nanoclay.
- the nanoparticle is a swellable nanoclay or adduct thereof.
- a swellable nanoclay has weakly bound ions in interlayer positions that may be hydrated or may absorb organic solvents. These swellable nanoclays generally possess a low cationic or anionic charge, i.e. less than about 0.9 units of charge per unit cell.
- swellable nanoclays i.e. those that swell in organic, non-aqueous solvents such as polar and nonpolar solvents. They may be prepared by reacting a water swellable nanoclay with an organic material that binds to the swellable nanoclay. Examples of such binding organic materials include, but are not limited to, a quaternary ammonium compound having the structure:
- R 1 , R 2 , R 3 and R 4 are each independently selected from H, a C 1 to C 22 alkyl, a C 1 to C 22 alkenyl, and a C 1 to C 22 aralkyl, provided that at least one of the R groups is such an alkyl, alkenyl or aralkyl; and
- X is the water swellable nanoclay.
- the swellable nanoclay may be amorphous or structured, i.e., including sheets or layers, wherein a combination of such layers is referred to as a lattice structure.
- suitable nanoclays having lattice structures include the pyrophillite (dioctahedral) type, the talc (trioctahedral) type, or mixtures thereof.
- Classes of suitable structured swellable nanoclays include, but are not limited to the smectite nanoclays, sepiolite nanoclays, zeolite nanoclays, polygorskyte nanoclays, or mixtures thereof.
- amorphous swellable nanoclays examples include allophone and imogolite.
- the nanoparticles are made from a starting material such as Nanomer 1.34TCN (available from Nanocor) having a particle size of 10 to 18 microns (10000-18000 nanometers).
- the nanoparticles are made from PGV (also available from Nanocor) having a particle size of 20 to 25 microns.
- exfoliated PGV having a particle size range of 1-3 nanometers is used.
- Nanomer 1.34TCN and Nanomer 1.30E having a particle size range of 1-9 nanometers is used.
- Boehmite alumina can have an average particle size distribution from 2 to 750 nm.
- Layered clay minerals can be used as starting materials for the exfoliated nanoparticles.
- the layered clay minerals suitable for use in the present invention include those in the geological classes of the smectites, the kaolins, the illites, the chlorites, the attapulgites and the mixed layer clays. Typical examples of specific clays belonging to these classes are the smectices, kaolins, illites, chlorites, attapulgites and mixed layer clays.
- Smectites for example, include montmorillonite, bentonite, pyrophyllite, hectorite, saponite, sauconite, nontronite, talc, beidellite, volchonskoite, stevensite, and vermiculite.
- montmorillonite nanoclay is preferred. See U.S. Pat. No. 5,869,033, which is incorporated by reference herein.
- Kaolins include kaolinite, dickite, nacrite, antigorite, anauxite, halloysite, indellite and chrysotile.
- Illites include bravaisite, muscovite, paragonite, phlogopite and biotite.
- Chlorites include corrensite, penninite, donbassite, sudoite, pennine and clinochlore.
- Attapulgites include sepiolite and polygorskyte.
- Mixed layer clays include allevardite and vermiculitebiotite. Variants and isomorphic substitutions of these layered clay minerals offer unique applications.
- Layered clay minerals may be either naturally occurring or synthetic.
- natural or synthetic hectorites, montmorillonites and bentonites may be used as the starting material for the nanoparticles.
- Natural clay minerals typically exist as layered silicate minerals and less frequently as amorphous minerals.
- a layered silicate mineral has SiO 4 tetrahedral sheets arranged into a two-dimensional network structure.
- a 2:1 type layered silicate mineral has a laminated structure of several to several tens of silicate sheets having a three layered structure in which a magnesium octahedral sheet or an aluminum octahedral sheet is sandwiched between two sheets of silica tetrahedral sheets.
- a sheet of an expandable layer silicate has a negative electric charge, and the electric charge is neutralized by the existence of alkali metal cations and/or alkaline earth metal cations.
- Smectite or expandable mica can be dispersed in water to form a sol with thixotropic properties.
- a complex variant of the smectite type clay can be formed by the reaction with various cationic organic or inorganic compounds.
- An example of such an organic complex an organophilic clay in which a dimethyldioctadecyl ammonium ion (a quaternary ammonium ion) is introduced by cation exchange. This has been industrially produced and used as a gellant of a coating.
- Synthetic nanoclays may be employed in the invention. With appropriate process control, the processes for the production of synthetic nanoclays does indeed yield primary particles that are nanoscale. However, the particles are not usually present in the form of discrete particles, but instead predominantly assume the form of agglomerates due to consolidation of the primary particles. Such agglomerates may reach diameters of several thousand nanometers, such that the desired characteristics associated with the nanoscale nature of the particles cannot be achieved.
- the particles may be deagglomerated, for example, by grinding as described in EP-A 637,616 or by dispersion in a suitable carrier medium, such as water or water/alcohol and mixtures thereof.
- Synthetic materials for making suitable nanoclays include layered hydrous silicate, layered hydrous aluminum silicate, fluorosilicate, mica-montmorillonite, hydrotalcite, lithium magnesium silicate and lithium magnesium fluorosilicate.
- An example of a substituted variant of lithium magnesium silicate is where the hydroxyl group is partially substituted with fluorine.
- Lithium and magnesium may also be partially substituted by aluminum.
- Lithium magnesium silicate may be isomorphically substituted by any member selected from the group consisting of magnesium, aluminum, lithium, iron, chromium, zinc and mixtures thereof.
- Synthetic hectorite for example as commercially marketed under the trade name LAPONITETM by Southern Clay Products, Inc., may be used as a starting material for the nanoparticles. There are many grades or variants and isomorphous substitutions of LAPONITETM marketed. Examples of commercial hectorites are LAPONITE BTM, LAPONITE STM, LAPONITE XLSTM, LAPONITE RDTM, LAPONITE XLGTM, and LAPONITE RDSTM.
- Synthetic hectorites do not contain any fluorine.
- An isomorphous substitution of the hydroxyl group with fluorine will produce synthetic clays referred to as sodium magnesium lithium fluorosilicates, which may also be used as the starting material.
- These sodium magnesium lithium fluoro silicates marketed as LAPONITETM and LAPONITE STM, may contain fluoride ions of up to approximately 10% by weight.
- the fluoride ion content useful in the compositions described herein is up to about 10 or more percent.
- LAPONITE BTM a sodium magnesium lithium fluorosilicate, has a flat, circular, plate-like shape, with an average particle size, depending on fluoride ion content, of about 25-100 nanometers.
- LAPONITE STM having a diameter of about 25-40 nm and thickness of about 1 nm may be used.
- Laponite XLSTM is used as the starting material for the nanoparticle, and silver is loaded thereon as the metal.
- Laponite XLS has tetrahedral silicate layers joined by octahedral magnesium and lithium hydroxyl bridges. This structure allows for exfoliation and modification by either intercalation or adsorption of metal to the nanoclay surface. In the case of intercalation, the metal is inserted between the layers of nanoclay. In the case of surface adsorption, the metal binds to the surface of the nanoclay. Laponite XLS is advantageous because it is synthetically consistent and pure, and exfoliates to form nanoparticles with minimal effort. The surface of the nanoparticle is covered with sodium ions to balance out the negative charge of the many silicate groups.
- the aspect ratio of the exfoliated nanoparticles in some cases, is of interest in forming films comprising the composite material with desired characteristics.
- the aspect ratio of dispersions can be adequately characterized by TEM (transmission electron microscopy).
- the aspect ratio of nanoparticles in one embodiment can be in the range of 100 to 250. In another embodiment, the aspect ratio of the nanoparticles is 200 to 350.
- the average aspect ratio of individual particles of LAPONITE BTM is approximately 20-40 and the average aspect ratio of individual particles of LAPONITE RDTM is approximately 10-15.
- LAPONITE BTM occurs in dispersions as essentially single clay particles or stacks of two clay particles.
- LAPONITE RDTM occurs essentially as stacks of two or more single clay particles.
- a high aspect ratio may be desirable for film formation.
- the aspect ratio of exfoliated nanoparticles dispersed in a suitable carrier medium, such as water, is also of interest.
- the aspect ratio of the nanoparticles in a dispersed medium is lower where several of the particles are aggregated.
- the aspect ratio of rod-shaped nanoparticles can be lower than that of disc-shaped or platelet-shaped nanoparticles while maintaining adequate film-forming properties.
- the aspect ratio of spheroid-shaped nanoparticles is generally less than or equal to about 5.
- Nanoparticles preferred for the embodiments presented here have aspect ratios of less than or equal to about 250. In other non-limiting embodiments, it may be desirable for the nanoparticles to have an aspect ratio of less than about 10.
- one or more metals are used to functionalize the nanoparticle.
- they are loaded onto the exfoliated nanoparticle by one of a variety of methods including intercalation, adsorption, or ion exchange.
- the metal retains its valuble properties, for example in the case of silver its anti-microbial properties, while on the nanoparticle.
- the term loaded, as used herein, includes complete coverage of the surface of the nanoparticle, or alternatively, only a portion thereof.
- the metal is selected from Groups 3 to 12 of the Periodic Table of Elements, aluminum, and magnesium.
- the metal is selected from silver, copper, zinc, manganese, platinum, palladium, gold, calcium, barium, aluminum, iron, and mixtures thereof.
- the metal is silver.
- the metal or metals may be selected based on the desired effect to be achieved through use of the composite material.
- silver may be selected for its known anti-microbial properties.
- the metal may be loaded onto the nanoparticle via intercalation.
- silver ions in particular, can be inserted among the various layers of layered nanoclay by positioning in a “hole” to maximize favorable interactions between the positively charged silver ion and the various types of oxygen in the silicate structure.
- Silver ions have been shown to have anti-microbial properties and Laponite that contains intercalated ionic silver, retains these properties. Intercalation is also possible with other metal ions, such as copper, zinc, manganese, etc.
- the metal may also be loaded onto the nanoparticle via ion exchange.
- the surface of Laponite platelets is composed mainly of sodium ions, which exist to balance out the negatively charged oxygen atoms donated by the silicate structure in the layer below.
- positively charged metal ions are added to a solution of exfoliated Laponite, a fraction of the surface sodium ions are displaced by the added metal cations.
- the metal may also be loaded onto the nanoparticle by adsorption.
- certain functional groups such as amine, ammonium, and carboxyl groups are strong binders to the face or edge of a platelet of Laponite.
- Metal ions can be modified by the addition of these ligands so that they are able to bind strongly to the surface of Laponite.
- the reaction sequence for one example is shown below:
- the final product Ag(NH 3 ) 2 OH
- Laponite The final product, Ag(NH 3 ) 2 OH, is contacted with Laponite, whereby the Ag(NH 3 ) 2 OH binds to the face of the Laponite.
- a metal ion is reduced to a metal (0) in the presence of a starting material, which is exfoliated to form a nanoparticle. Reduction and exfoliation may take place in sequence (either step happening first) or simultaneously upon contacting of the metal with the starting material/exfoliated nanoparticle. The metal is thereby loaded onto the surface of the exfoliated nanoparticle.
- the metal is silver, which is loaded onto the nanoparticle via intercalation using the Tollen's reagent.
- the Tollen's reagent is a known silver species able to undergo reduction by either an aldehyde or ketone to form silver metal (0):
- the composite material may in incorporated into a variety of systems, materials and compositions, including liquids, solids, gels, coating compositions, cosmetic and pharmaceutical compositions and the like.
- the composite material may be incorporated into structures or articles of manufacture such as absorbent articles, wound care articles, soft surfaces, or hard surfaces.
- Compositions containing the composite material may be solutions or dry materials, that are coated, applied, extruded, sprayed, and so forth as further described below. Such compositions may have end uses in manufacturing, commercial, industrial, personal, or domestic applications.
- Systems comprising the composite material can be employed to bring about certain, desired benefits, for example improved fluid absorbency, wettability, strike-through, comfort, malodor control, lubricity, anti-inflammatory properties, anti-microbial properties, anti-fungal properties, modification of surface friction, flexibility, transparency, modulus, tensile strength, color enhancement, viscosity, smoothness, or gel strength.
- the presence of the composite material in a composition does not affect the desirable properties of the composition, for example transparency. Addition of the composite material to a liquid composition, for instance, will not alter the transparency or color of the resultant composition as compared to the original, liquid material not containing the composite material. Moreover, since nanoparticles possess large surface areas, the composite material will also allow for higher concentrations of metals to be included in the overall formulation, such as in the treatment of infections.
- compositions of the invention may comprise the composite material and any other ingredients appropriate for the intended use of the compositions.
- Some compositions of the invention may comprise: (a) the composite material, which may be an effective amount of the composite material; (b) a suitable carrier medium; and (c) optionally one or more adjunct ingredients.
- the adjunct ingredients may be, for example, surfactants or charged functionalized molecules exhibiting properties selected from the group consisting of hydrophilic, hydrophobic and mixtures thereof associated with at least some of the composite material, or both.
- an effective amount of composite material described above can be included in compositions useful for coating a variety of soft surfaces in need of treatment.
- an effective amount of composite material refers to the quantity of composite material necessary to impart the desired benefit to the soft surface.
- Such effective amounts are readily ascertained by one of ordinary skill in the art and is based on many factors, such as the particular composite material used, the nature of the soft surface whether a liquid or dry (e.g., granular, powder) composition is required, and the like.
- the composition may be applied to the surface(s) by washing, spraying, dipping, painting, wiping, or by other manner in order to deliver a coating, especially a transparent coating that covers at least about 0.5% of the surface, or any greater percentage of the surface, including but not limited to: at least about 5%, at least about 10%, at least about 30%, at least about 50%, at least about 80%, and at least about 100% of the surface. Accordingly, the coating may be continuous or discontinuous.
- the viscosity of the coating composition should be such that it will be capable of passing through the nozzle of a spray device. Such viscosities are well known, and are incorporated herein by reference.
- the composition may be capable of undergoing shear thinning so that it is capable of being sprayed.
- Suitable carrier mediums for the compositions containing the composite material include liquids, solids and gases.
- One suitable carrier medium is water, which can be distilled, deionized, or tap water. Water is valuable due to its low cost, availability, safety, and compatibility.
- the pH of the liquid, in particular water may be adjusted through the addition of acid or base.
- Aqueous carrier mediums are also easy apply to a substrate and then dried. Though aqueous carrier mediums are more common than dry, nonaqueous mediums, the composition can exist as a dry powder, granule or tablet or encapsulated complex form.
- the carrier medium can comprise a low molecular weight organic solvent.
- the solvent is highly soluble in water, e.g., ethanol, methanol, propanol, isopropanol, ethylene glycol, acetone, and the like, and mixtures thereof.
- the solvent can be used at any suitable level. Several non-limiting examples, include a level of up to about 50%, or more; from about 0.1% to about 25%; from about 2% to about 15%, and from about 5% to about 10%, by weight of the total composition. Factors to consider when a high level of solvent is used in the composition are odor, flammability, dispersancy of the nanoparticles and environmental impact.
- the carrier medium may also comprise a film former, which when dried, forms a continuous film.
- film formers are polyvinyl alcohol, polyethylene oxide, polypropylene oxide, acrylic emulsions, hydroxypropylmethyl cellulose.
- Adjunct ingredients that may be used in compositions containing the composite material include polymers and copolymers with at least one segment or group which comprises functionality that serves to anchor the composite material to a substrate. These polymers may also comprise at least one segment or group that serves to provide additional character to the polymer, such as hydrophilic or hydrophobic properties.
- anchoring segments or groups examples include: polyamines, quaternized polyamines, amino groups, quaternized amino groups, and corresponding amine oxides; zwitterionic polymers; polycarboxylates; polyethers; polyhydroxylated polymers; polyphosphonates and polyphosphates; and polymeric chelants.
- hydrophilizing segments or groups include: ethoxylated or alkoxylated polyamines; polyamines; polycarboxylated polyamines; water soluble polyethers; water soluble polyhydroxylated groups or polymers, including saccharides and polysaccharides; water soluble carboxylates and polycarboxylates; water soluble anionic groups such as carboxylates, sulfonates, sulfates, phosphates, phosphonates and polymers thereof; water soluble amines, quaternaries, amine oxides and polymers thereof; water soluble zwitterionic groups and polymers thereof; water soluble amides and polyamides; and water soluble polymers and copolymers of vinylimidazole and vinylpyrrolidone.
- hydrophobizing segments or groups include: alkyl, alkylene, and aryl groups, and polymeric aliphatic or aromatic hydrocarbons; fluorocarbons and polymers comprising fluorocarbons; silicones; hydrophobic polyethers such as poly(styrene oxide), poly(propylene oxide), polybutylene oxide), poly(tetramethylene oxide), and poly(dodecyl glycidyl ether); and hydrophobic polyesters such as polycaprolactone and poly(3-hydroxycarboxylic acids).
- hydrophilic surface polymers that may be incorporated into the compositions of the invention include, but are not limited to: ethoxylated or alkoxylated polyamines; polycarboxylated polyamines; polycarboxylates including but not limited to polyacrylate; polyethers; polyhydroxyl materials; polyphosphates and phosphonates.
- hydrophobic surface polymers that may be incorporated into the compositions of the invention include alkylated polyamines include, but are not limited to: polyethyleneimine alkylated with fatty alkylating agents such as dodecyl bromide, octadecyl bromide, oleyl chloride, dodecyl glycidyl ether and benzyl chloride or mixtures thereof; and polyethyleneimine acylated with fatty acylating agents such as methyl dodecanoate and oleoyl chloride; silicones including, but not limited to: polydimethylsiloxane having pendant aminopropyl or aminoethylaminopropyl groups and fluorinated polymers including, but not limited to: polymers including as monomers (meth)acrylate esters of perfluorinated or highly fluorinated alkyl groups.
- fatty alkylating agents such as dodecyl bromide, octadecyl bromid
- Non-polymeric surface modifying materials that may be used as adjunct ingredients include fatty amines and quaternized amines including: ditallowedimethylammonium chloride; octadecyltrimethylammonium bromide; dioleyl amine; and benzyltetradecyldimethylammonium chloride. Silicone-based surfactants, fatty zwitterionic surfactants and fatty amine oxides may also be incorporated into the composition.
- Surfactants are also optional adjunct ingredients. Surfactants are especially useful in the composition as wetting agents to facilitate the dispersion.
- Suitable surfactants can be selected from the group including anionic surfactants, cationic surfactants, nonionic surfactants, amphoteric surfactants, ampholytic surfactants, zwitterionic surfactants and mixtures thereof.
- suitable nonionic, anionic, cationic, ampholytic, zwitterionic and semi-polar nonionic surfactants are disclosed in U.S. Pat. Nos. 5,707,950 and 5,576,282.
- Nonionic surfactants may be characterized by an HLB (hydrophilic-lipophilic balance) of from 5 to 20, alternatively from 6 to 15.
- silicone surfactants and/or silicones. They can be used alone and/or alternatively in combination with other surfactants described herein above.
- Nonlimiting examples of silicone surfactants are the polyalkylene oxide polysiloxanes having a dimethyl polysiloxane hydrophobic moiety and one or more hydrophilic polyalkylene side chains
- the surfactant is should be formulated to be compatible with the composite material, carrier medium and other adjunct ingredients present in the composition.
- compositions can contain other adjunct ingredients, including but not limited to alkalinity sources, antioxidants, anti-static agents, chelating agents, aminocarboxylate chelators, metallic salts, photoactive inorganic metal oxides, odor-controlling materials, perfumes, photoactivators, polymers, preservatives, processing aids, pigments, and pH control agents, solubilizing agents, zeolites, and mixtures thereof.
- adjunct ingredients including but not limited to alkalinity sources, antioxidants, anti-static agents, chelating agents, aminocarboxylate chelators, metallic salts, photoactive inorganic metal oxides, odor-controlling materials, perfumes, photoactivators, polymers, preservatives, processing aids, pigments, and pH control agents, solubilizing agents, zeolites, and mixtures thereof.
- adjunct ingredients including but not limited to alkalinity sources, antioxidants, anti-static agents, chelating agents, aminocarboxylate chelators, metallic salts, photoactive inorganic metal oxides,
- Coating compositions comprising the composite material can be used on all types of soft surfaces, including but not limited to woven fibers, nonwoven fibers, leather, plastic (for example, toothbrush handles, synthetic film, filaments, toothbrush bristles), and mixtures thereof.
- the soft surfaces of interest herein may comprise any known type of soft surface, including but not limited to those associated with disposable absorbent articles including but not limited to covers or topsheets, absorbent cores, transfer layers, absorbent inserts, and backsheets including those outer layers made from breathable and nonbreathable films.
- such a coating composition can be applied to hard surfaces, and provide benefits thereto.
- the soft surface may comprise one or more fibers.
- a fiber is defined as a fine hairlike structure, of vegetable, mineral, or synthetic origin. Commercially available fibers have diameters ranging from less than about 0.001 mm (about 0.00004 in) to more than about 0.2 mm (about 0.008 in) and they come in several different forms: short fibers (known as staple, or chopped), continuous single fibers (filaments or monofilaments), untwisted bundles of continuous filaments (tow), and twisted bundles of continuous filaments (yarn). Fibers are classified according to their origin, chemical structure, or both.
- They can be braided into ropes and cordage, made into felts (also called nonwovens or nonwoven fabrics), woven or knitted into textile fabrics, or, in the case of high-strength fibers, used as reinforcements in composites-that is, products made of two or more different materials.
- the soft surfaces may comprise fibers made by nature (natural fibers), made by man (synthetic or man-made), or combinations thereof.
- natural fibers include but are not limited to: animal fibers such as wool, silk, fur, and hair; vegetable fibers such as cellulose, cotton, flax, linen, and hemp; and certain naturally occurring mineral fibers.
- Synthetic fibers can be derived from natural fibers or not. Examples of synthetic fibers which are derived from natural fibers include but are not limited to rayon and lyocell, both of which are derived from cellulose, a natural polysaccharide fiber. Synthetic fibers which are not derived from natural fibers can be derived from other natural sources or from mineral sources.
- Example synthetic fibers derived from natural sources include but are not limited to polysaccharides such as starch.
- Example fibers from mineral sources include but are not limited to polyolefin fibers such as polypropylene and polyethylene fibers, which are derived from petroleum, and silicate fibers such as glass and asbestos.
- Synthetic fibers are commonly fowled, when possible, by fluid handling processes (e.g., extruding, drawing, or spinning a fluid such as a resin or a solution). Synthetic fibers are also formed by solid handling size reduction processes (e.g., mechanical chopping or cutting of a larger object such as a monolith, a film, or a fabric).
- Disposable absorbent articles such as pantiliners, sanitary napkins, interlabial devices, adult incontinent devices, breast pads, shoe insoles, bandages, and diapers typically are made from absorbent, nonwoven materials (including fibers) and are well known in the art. These articles typically have a fluid permeable body-facing side and fluid impermeable garment facing side. Additionally, such articles may include an absorbent core for retaining fluids therebetween. Addition of the composite material to an article of manufacture such as the absorbent core of a disposable, absorbent article may help control malodor formation and increase absorbency.
- composite material examples include but are not limited to use in dental abrasives for toothpaste, odor absorbents, and oral rinses.
- Other uses for the composite material include ophthalmic solutions and devices such as contact lenses.
- compositions comprising the composite material.
- These may be in the form of creams, lotions, gels, foams, oils, ointments, or powders for application to tissues including skin, hair, nails, and mucosa such as vaginal or oral mucosa.
- Such compositions may be formulated as either leave-on products or rinse-off products.
- such compositions may also be in the form of ophthalmic solutions or ointments, which are applied directly to the eye.
- the composition contains an anti-acne agent such as salicylic acid or benzoyl peroxide.
- an anti-acne agent such as salicylic acid or benzoyl peroxide.
- the composition is a personal lubricant such as those disclosed in U.S. Ser. Nos. 10/137,509; 10/390,511; and 10/389,871, filed May 1, 2002; Mar. 17, 2003; Mar. 17, 2003, respectively.
- These applications describe warming lubricant compositions that are non-toxic and non-irritating and that can be used as personal lubricants designed to come into contact with the skin or mucosa. When mixed with water, such compositions increase in temperature or generate warmth. This has a soothing effect on the tissues to which these compositions are applied.
- These compositions are preferably substantially anhydrous and preferably contain at least one polyhydric alcohol.
- Cosmetic and pharmaceutical compositions may contain a variety of active agents known in the art such as skin lightening agents, skin pigmentation darkening agents, anti-acne agents, sebum modulators, shine control agents, anti-microbial agents, anti-fungals, anti-inflammatory agents, anti-mycotic agents, anti-parasite agents, external analgesics, sunscreens, photoprotectors, antioxidants, keratolytic agents, detergents, surfactants, moisturizers, nutrients, vitamins, energy enhancers, anti-perspiration agents, astringents, deodorants, hair removers, firming agents, anti-callous agents, and agents for hair, nail, or skin conditioning.
- active agents such as skin lightening agents, skin pigmentation darkening agents, anti-acne agents, sebum modulators, shine control agents, anti-microbial agents, anti-fungals, anti-inflammatory agents, anti-mycotic agents, anti-parasite agents, external analgesics, sunscreens, photoprotectors, antioxidants,
- Formulations for topical or mucosal application are well known in the art. Excipients used by those skilled in the art in such formulations may be used with the composite material herein, provided they are compatible.
- compositions of the present invention can be applied to a surface and optionally allowed to dry on the surface, optionally repeating the application and drying steps as needed. In some embodiments of the methods described herein, including, but not limited to when applying more than one coating, it is not necessarily required to dry the coating(s) between applications.
- silver ions were reduced in the presence of Laponite using the Tollen's reagent, which is able to undergo reduction by either an aldehyde or ketone to form silver metal via the following reaction:
- the Tollen's reagent was prepared by adding two drops of 10% NaOH to 5 mL of 5% AgNO 3 to form a gray-brown precipitate. This precipitate was then dissolved by the dropwise addition of 2% NH 4 OH to yield a total Tollen's reagent volume of 30 mL.
- a solution of silver-loaded Laponite XLS was prepared by adding 600 mg of Laponite XLS to 50 mL of distilled water and using a magnetic stirrer to exfoliate for 20 minutes. To this solution, 800 mg of glucose were added and the stirring continued for 10 minutes to ensure complete dissolution of the glucose. To this, 10 mL of Tollen's reagent as prepared above were added. After two hours of continuous stirring, the solution turned golden yellow in color. Further reaction time yielded a dark amber-brown solution. Samples prepared for particle size analysis and TEM analysis were diluted by a factor of 10 to prevent particle aggregation. The particle size of the nanoparticles dictates the color of the solution caused by a surface plasmon resonance phenomenon. For silver particles, a yellow color has been determined to have the smallest particle size possible. The particle size distribution of the resulting nanoparticles is shown in FIG. 1 .
- Nanoparticles of silver-laponite were prepared by reduction with sodium citrate, although the reduction by this method was more difficult to control.
- Citric acid was added to an exfoliated Laponite XLS solution, followed by the addition of silver nitrate. 10% NaOH was added dropwise to form the sodium salt of citric acid until the solution turned faintly yellow. In many cases, the over-addition of sodium hydroxide caused the silver particles to fall out of solution.
- Nanoparticles of silver-loaded Laponite XLS can be prepared by hydrazine reduction as follows: 5 g of Laponite XLS are added to 995 g of deionized water and stirred for 20 minutes to exfoliate the Laponite XLS. 20 mg of 55% hydrazine hydrate is added to the Laponite XLS dispersion and the solution is stirred for 1 minute. 77 mg of AgNO 3 is dissolved in deionized water. The AgNO 3 solution is added dropwise to the Laponite—hydrazine solution to form a golden-yellow solution containing 0.005% silver-loaded Laponite XLS.
- Another solution of silver-loaded Laponite XLS was prepared similarly to Example 1, but the order of the components was altered. Glucose and Tollen's reagent were mixed in a separate vessel and once the color of the solution turned faintly gray, this mixture was added to the solution of exfoliated Laponite XLS. After a short period of stirring, the solution turned amber-yellow. This solution was diluted by a factor of 10 for particle size analysis. The particle size distribution of the resulting material is shown in FIG. 2 .
- a sample was prepared by adding 200 mg of Laponite XLS to 100 mL of water and stirring to exfoliate. The sample was analyzed for particle size. The results are shown in FIG. 3 .
- Example 6 The sample of Example 6 was diluted by a factor of 50. The sample was analyzed for particle size. The results are shown in FIG. 4 .
- Examples 1-7 indicate that as a solution of Laponite XLS in water is diluted, the distribution of particle sizes changes.
- the particle size of silver-loaded Laponite XLS was smaller, on average, than Laponite XLS alone, indicating that the addition of silver to the solution aided in the Laponite XLS exfoliation process.
- Example 1 shows a single particle size distribution, averaging 4.1 nm in size.
- Example 5 showed a bimodal particle size distribution with the averages centered on 4.1 nm and 11 nm. This indicates the formation of two different types of particles. It is possible that this solution contained silver-loaded Laponite XLS and colloidal silver with no Laponite core.
- Example 1 To verify that the Laponite XLS was being coated with silver, TEM (transmission electron microscopic) images and EDX (Energy Dispersive X-Ray) analysis were performed on Examples 1 and 6. The data confirmed that the composite material of Example 1 contained silver-loaded Laponite XLS particles, as opposed to a mixture of colloidal silver and Laponite XLS. Elemental analysis showed the presence of Na, Mg, Si, and Ag (Cu was present in the TEM grid). The data also revealed that particles of very small size ( ⁇ 1 nm), determined to be uncoated Laponite XLS, were also present.
- a solution containing silver-loaded Laponite XLS particles was prepared as follows. 4.51 g of Laponite XLS was added to 900 mL of deionized water. The solution was stirred for 1 hour and labeled Solution A. To 400 mL of Solution A, 15 mg of NaBH 4 was added. This solution was labeled Solution B. 124 mg of AgNO 3 was dissolved in 5 mL of deionized water; and this was added dropwise to Solution B to form an amber brown solution of 0.02% silver loaded onto Laponite XLS. Following the above procedure, 0.01%, 0.005% and 0.0025% silver loaded Laponite XLS solutions were prepared.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Geometry (AREA)
- Optics & Photonics (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Composite materials comprising nanoparticles functionalized with metals are disclosed. The composite materials may be used in a variety of applications, including in coating compositions, cosmetic and pharmaceutical compositions, absorbent articles, and the like.
Description
- This application claims priority from U.S. provisional application Ser. No. 60/515,758 filed Oct. 30, 2003.
- The present invention relates to composite materials that are functionalized nanoparticles and in particular, metal-loaded nanoclays. Additionally, the present invention relates to a method of forming such composite materials.
- For centuries, silver metal has been known to be an agent capable of killing many different microbial species. It was commonly used to purify drinking solutions or administered to sick individuals before the existence of modern antibiotics. Even after the discovery of penicillin and its descendents, colloidal silver solutions were often used in cases in which troublesome bacteria had become resistant to antibiotics.
- Colloidal silver solutions are commercially available today. They are often unstable, however, and have a short shelf life. This is due to the tendency of the silver particles to aggregate and form clusters so large that they are no longer suspended in solution. For this reason, undesirable gelling agents are added to solutions to keep the silver particles suspended by preventing particle aggregation. Another problem of the commercially available solutions is that the majority of the silver content is usually found to be silver ions. This poses a large problem in medical applications where silver ions rapidly combine with ubiquitous chloride to form an insoluble white precipitate.
- Nanoparticles have been known to be used as fillers as disclosed in U.S. Pat. No. 6,492,453, as coatings as disclosed in US 2003/0185964 and as foam components as disclosed in U.S. Pat. No. 6,518,324.
- Nanoparticle systems are disclosed in US 2002/0150678 as being used in a composition and a method to impart surface modifying benefits to soft and hard surfaces. In particular, this application discloses a soft surface coating for articles such as fabrics and garments.
- Inorganic particulates, such as, clays, silicates, and alumina have been widely used in combination with adjunct detergent and laundry compounds to impart some form of antistatic control and/or fabric softening benefit.
- The present invention relates to composite materials comprising metal loaded onto exfoliated nanoparticles. Such functionalized nanoparticles may be incorporated into solid and liquid materials to enhance or modify their bulk physical and performance characteristics. In one embodiment, the metal is silver and the nanoparticle comprises a nanoclay. Silver ion is reduced to its neutral metal state) (Ag0) and loaded onto the nanoclay. Silver-coated nanoclays in particular have excellent antimicrobial properties, and represent a less expensive alternative to the use of colloidal silver solutions. Such nanoparticles made according to the invention are stable and use less silver metal to generate the same surface area as solid silver particles, making them more cost efficient.
- The invention provides a composite material comprising (a) an exfoliated nanoparticle having a surface and (b) a metal selected from
Groups 3 to 12, aluminum and magnesium, wherein the metal is loaded onto the surface of the nanoparticle. - The invention also provides a method of making a composite material comprising an exfoliated nanoparticle having a metal coating, which method comprises: (a) reducing a metal ion to metal; (b) exfoliating a starting material to form a nanoparticle; and (c) contacting the metal with the exfoliated nanoparticle, whereby steps (a) and (b) may be performed sequentially in any order or simultaneously and the metal is loaded onto the surface of the exfoliated nanoparticle.
- The invention further provides solutions, solids, gels, coating compositions, cosmetic and pharmaceutical compositions, and articles of manufacture comprising such a composite material.
-
FIG. 1 shows the particle size distribution of the material of Example 1. -
FIG. 2 shows the particle size distribution of the material of Example 5. -
FIG. 3 shows the particle size distribution of the material of Example 6. -
FIG. 4 shows the particle size distribution of the material of Example 7. - Every limit given throughout this specification includes every lower or higher limit, as the case may be, as if such lower or higher limit was expressly written herein. Every range given throughout this specification includes every narrower range that falls within such broader range, as if such narrower ranges were all expressly written herein.
- Nanoparticles as used herein means particles (including but not limited to rod-shaped particles, disc-shaped particles, platelet-shaped particles, tetrahedral-shaped particles), fibers, nanotubes, or any other materials having dimensions on the nano scale. In one embodiment, the nanoparticles have an average particle size of about 1 to about 1000 nanometers, preferably 2 to about 750 nanometers. That is, the nanoparticles have a largest dimension (e.g., a diameter or length) of about 1 to 1000 nm. Nanotubes can include structures up to 1 centimeter long, alternatively with a particle size from about 2 to about 50 nanometers. Nanoparticles have very high surface-to-volume ratios. The nanoparticles may be crystalline or amorphous. A single type of nanoparticle may be used, or mixtures of different types of nanoparticles may be used. If a mixture of nanoparticles is used they may be homogeneously or non-homogeneously distributed in the composite material or a system or composition containing the composite material.
- Non-limiting examples of suitable particle size distributions of nanoparticles are those within the range of about 2 nm to less than about 750 nm, alternatively from about 2 nm to less than about 200 nm, and alternatively from about 2 nm to less than about 150 nm. It should also be understood that certain particle size distributions may be useful to provide certain benefits, and other ranges of particle size distributions may be useful to provide other benefits (for instance, color enhancement requires a different particle size range than the other properties). The average particle size of a batch of nanoparticles may differ from the particle size distribution of those nanoparticles. For example, a layered synthetic silicate can have an average particle size of about 25 nanometers while its particle size distribution can generally vary between about 10 nm to about 40 nm. It should be understood that the particle size distributions described herein are for nanoparticles when they are dispersed in an aqueous medium and the average particle size is based on the mean of the particle size distribution.
- According to the invention, the nanoparticles are exfoliated. In particular, a starting material is exfoliated or disbursed to form the nanoparticles. Such starting material may have an average size of up to about 50 microns (50,000 nanometers).
- The nanoparticle may comprise for example natural or synthetic nanoclays, including those made from amorphous or structured clays.
- In one embodiment, the exfoliated nanoparticle is a nanoclay. In a further embodiment, the nanoparticle is a swellable nanoclay or adduct thereof. A swellable nanoclay has weakly bound ions in interlayer positions that may be hydrated or may absorb organic solvents. These swellable nanoclays generally possess a low cationic or anionic charge, i.e. less than about 0.9 units of charge per unit cell.
- As used herein, “adducts” means oil swellable nanoclays, i.e. those that swell in organic, non-aqueous solvents such as polar and nonpolar solvents. They may be prepared by reacting a water swellable nanoclay with an organic material that binds to the swellable nanoclay. Examples of such binding organic materials include, but are not limited to, a quaternary ammonium compound having the structure:
-
R1R2R3R4N+X− - wherein
- R1, R2, R3 and R4 are each independently selected from H, a C1 to C22 alkyl, a C1 to C22 alkenyl, and a C1 to C22 aralkyl, provided that at least one of the R groups is such an alkyl, alkenyl or aralkyl; and
- X is the water swellable nanoclay.
- The swellable nanoclay may be amorphous or structured, i.e., including sheets or layers, wherein a combination of such layers is referred to as a lattice structure. Examples of suitable nanoclays having lattice structures include the pyrophillite (dioctahedral) type, the talc (trioctahedral) type, or mixtures thereof. Classes of suitable structured swellable nanoclays include, but are not limited to the smectite nanoclays, sepiolite nanoclays, zeolite nanoclays, polygorskyte nanoclays, or mixtures thereof.
- Examples of amorphous swellable nanoclays include allophone and imogolite.
- In one embodiment, the nanoparticles are made from a starting material such as Nanomer 1.34TCN (available from Nanocor) having a particle size of 10 to 18 microns (10000-18000 nanometers). In another embodiment, the nanoparticles are made from PGV (also available from Nanocor) having a particle size of 20 to 25 microns. In another embodiment, exfoliated PGV having a particle size range of 1-3 nanometers is used. In other embodiments, Nanomer 1.34TCN and Nanomer 1.30E having a particle size range of 1-9 nanometers is used.
- Boehmite alumina can have an average particle size distribution from 2 to 750 nm.
- Layered clay minerals can be used as starting materials for the exfoliated nanoparticles. The layered clay minerals suitable for use in the present invention include those in the geological classes of the smectites, the kaolins, the illites, the chlorites, the attapulgites and the mixed layer clays. Typical examples of specific clays belonging to these classes are the smectices, kaolins, illites, chlorites, attapulgites and mixed layer clays. Smectites, for example, include montmorillonite, bentonite, pyrophyllite, hectorite, saponite, sauconite, nontronite, talc, beidellite, volchonskoite, stevensite, and vermiculite. In one embodiment, montmorillonite nanoclay is preferred. See U.S. Pat. No. 5,869,033, which is incorporated by reference herein. Kaolins include kaolinite, dickite, nacrite, antigorite, anauxite, halloysite, indellite and chrysotile. Illites include bravaisite, muscovite, paragonite, phlogopite and biotite. Chlorites include corrensite, penninite, donbassite, sudoite, pennine and clinochlore. Attapulgites include sepiolite and polygorskyte. Mixed layer clays include allevardite and vermiculitebiotite. Variants and isomorphic substitutions of these layered clay minerals offer unique applications.
- Layered clay minerals may be either naturally occurring or synthetic. For example, natural or synthetic hectorites, montmorillonites and bentonites may be used as the starting material for the nanoparticles.
- Natural clay minerals typically exist as layered silicate minerals and less frequently as amorphous minerals. A layered silicate mineral has SiO4 tetrahedral sheets arranged into a two-dimensional network structure. A 2:1 type layered silicate mineral has a laminated structure of several to several tens of silicate sheets having a three layered structure in which a magnesium octahedral sheet or an aluminum octahedral sheet is sandwiched between two sheets of silica tetrahedral sheets.
- A sheet of an expandable layer silicate has a negative electric charge, and the electric charge is neutralized by the existence of alkali metal cations and/or alkaline earth metal cations. Smectite or expandable mica can be dispersed in water to form a sol with thixotropic properties. Further, a complex variant of the smectite type clay can be formed by the reaction with various cationic organic or inorganic compounds. An example of such an organic complex, an organophilic clay in which a dimethyldioctadecyl ammonium ion (a quaternary ammonium ion) is introduced by cation exchange. This has been industrially produced and used as a gellant of a coating.
- Synthetic nanoclays may be employed in the invention. With appropriate process control, the processes for the production of synthetic nanoclays does indeed yield primary particles that are nanoscale. However, the particles are not usually present in the form of discrete particles, but instead predominantly assume the form of agglomerates due to consolidation of the primary particles. Such agglomerates may reach diameters of several thousand nanometers, such that the desired characteristics associated with the nanoscale nature of the particles cannot be achieved. The particles may be deagglomerated, for example, by grinding as described in EP-A 637,616 or by dispersion in a suitable carrier medium, such as water or water/alcohol and mixtures thereof.
- Synthetic materials for making suitable nanoclays include layered hydrous silicate, layered hydrous aluminum silicate, fluorosilicate, mica-montmorillonite, hydrotalcite, lithium magnesium silicate and lithium magnesium fluorosilicate. An example of a substituted variant of lithium magnesium silicate is where the hydroxyl group is partially substituted with fluorine. Lithium and magnesium may also be partially substituted by aluminum. Lithium magnesium silicate may be isomorphically substituted by any member selected from the group consisting of magnesium, aluminum, lithium, iron, chromium, zinc and mixtures thereof.
- Synthetic hectorite, for example as commercially marketed under the trade name LAPONITE™ by Southern Clay Products, Inc., may be used as a starting material for the nanoparticles. There are many grades or variants and isomorphous substitutions of LAPONITE™ marketed. Examples of commercial hectorites are LAPONITE B™, LAPONITE S™, LAPONITE XLS™, LAPONITE RD™, LAPONITE XLG™, and LAPONITE RDS™.
- Synthetic hectorites do not contain any fluorine. An isomorphous substitution of the hydroxyl group with fluorine will produce synthetic clays referred to as sodium magnesium lithium fluorosilicates, which may also be used as the starting material. These sodium magnesium lithium fluoro silicates, marketed as LAPONITE™ and LAPONITE S™, may contain fluoride ions of up to approximately 10% by weight. The fluoride ion content useful in the compositions described herein is up to about 10 or more percent. LAPONITE B™, a sodium magnesium lithium fluorosilicate, has a flat, circular, plate-like shape, with an average particle size, depending on fluoride ion content, of about 25-100 nanometers. For example, in one non-limiting embodiment, LAPONITE S™ having a diameter of about 25-40 nm and thickness of about 1 nm may be used. Another variant, called LAPONITE S™, contains about 6% of tetrasodium pyrophosphate as an additive.
- In one embodiment, Laponite XLS™ is used as the starting material for the nanoparticle, and silver is loaded thereon as the metal. Laponite XLS has tetrahedral silicate layers joined by octahedral magnesium and lithium hydroxyl bridges. This structure allows for exfoliation and modification by either intercalation or adsorption of metal to the nanoclay surface. In the case of intercalation, the metal is inserted between the layers of nanoclay. In the case of surface adsorption, the metal binds to the surface of the nanoclay. Laponite XLS is advantageous because it is synthetically consistent and pure, and exfoliates to form nanoparticles with minimal effort. The surface of the nanoparticle is covered with sodium ions to balance out the negative charge of the many silicate groups.
- The aspect ratio of the exfoliated nanoparticles, in some cases, is of interest in forming films comprising the composite material with desired characteristics. The aspect ratio of dispersions can be adequately characterized by TEM (transmission electron microscopy).
- The aspect ratio of nanoparticles in one embodiment can be in the range of 100 to 250. In another embodiment, the aspect ratio of the nanoparticles is 200 to 350.
- For example, the average aspect ratio of individual particles of LAPONITE B™ is approximately 20-40 and the average aspect ratio of individual particles of LAPONITE RD™ is approximately 10-15. LAPONITE B™ occurs in dispersions as essentially single clay particles or stacks of two clay particles. LAPONITE RD™ occurs essentially as stacks of two or more single clay particles.
- In some embodiments, a high aspect ratio may be desirable for film formation. The aspect ratio of exfoliated nanoparticles dispersed in a suitable carrier medium, such as water, is also of interest. The aspect ratio of the nanoparticles in a dispersed medium is lower where several of the particles are aggregated.
- In certain embodiments, it may be desirable for at least some individual (non-aggregated) platelet and disc-shaped nanoparticles to have at least one dimension that is greater than or equal to about 0.5 nm, and an aspect ratio of greater than or equal to about 15. Larger aspect ratios may be more desirable for platelet and disc-shaped nanoparticles than for rod-shaped nanoparticles.
- The aspect ratio of rod-shaped nanoparticles can be lower than that of disc-shaped or platelet-shaped nanoparticles while maintaining adequate film-forming properties. In certain non-limiting embodiments, it may be desirable for at least some of the individual rod-shaped nanoparticles to have at least one dimension that is greater than or equal to about 0.5 nm, and an aspect ratio of greater than or equal to about 3.
- The aspect ratio of spheroid-shaped nanoparticles is generally less than or equal to about 5. Nanoparticles preferred for the embodiments presented here have aspect ratios of less than or equal to about 250. In other non-limiting embodiments, it may be desirable for the nanoparticles to have an aspect ratio of less than about 10.
- According to the invention, one or more metals are used to functionalize the nanoparticle. In particular, they are loaded onto the exfoliated nanoparticle by one of a variety of methods including intercalation, adsorption, or ion exchange. Advantageously, the metal retains its valuble properties, for example in the case of silver its anti-microbial properties, while on the nanoparticle. The term loaded, as used herein, includes complete coverage of the surface of the nanoparticle, or alternatively, only a portion thereof.
- In one embodiment, the metal is selected from
Groups 3 to 12 of the Periodic Table of Elements, aluminum, and magnesium. Preferably, the metal is selected from silver, copper, zinc, manganese, platinum, palladium, gold, calcium, barium, aluminum, iron, and mixtures thereof. In a particularly preferred embodiment, the metal is silver. - The metal or metals may be selected based on the desired effect to be achieved through use of the composite material. For example, silver may be selected for its known anti-microbial properties.
- The metal may be loaded onto the nanoparticle via intercalation. For example, silver ions, in particular, can be inserted among the various layers of layered nanoclay by positioning in a “hole” to maximize favorable interactions between the positively charged silver ion and the various types of oxygen in the silicate structure. Silver ions have been shown to have anti-microbial properties and Laponite that contains intercalated ionic silver, retains these properties. Intercalation is also possible with other metal ions, such as copper, zinc, manganese, etc.
- The metal may also be loaded onto the nanoparticle via ion exchange. For example, the surface of Laponite platelets is composed mainly of sodium ions, which exist to balance out the negatively charged oxygen atoms donated by the silicate structure in the layer below. When positively charged metal ions are added to a solution of exfoliated Laponite, a fraction of the surface sodium ions are displaced by the added metal cations.
- The metal may also be loaded onto the nanoparticle by adsorption. For example, certain functional groups such as amine, ammonium, and carboxyl groups are strong binders to the face or edge of a platelet of Laponite. Metal ions can be modified by the addition of these ligands so that they are able to bind strongly to the surface of Laponite. The reaction sequence for one example is shown below:
-
2AgNO3+2NaOH→Ag2O+2NaNO3+H2O -
Ag2O+4NH3+H2O→2Ag(NH3)2OH - The final product, Ag(NH3)2OH, is contacted with Laponite, whereby the Ag(NH3)2OH binds to the face of the Laponite.
- In one embodiment of the invention a metal ion is reduced to a metal (0) in the presence of a starting material, which is exfoliated to form a nanoparticle. Reduction and exfoliation may take place in sequence (either step happening first) or simultaneously upon contacting of the metal with the starting material/exfoliated nanoparticle. The metal is thereby loaded onto the surface of the exfoliated nanoparticle.
- In one embodiment of the invention, the metal is silver, which is loaded onto the nanoparticle via intercalation using the Tollen's reagent. The Tollen's reagent is a known silver species able to undergo reduction by either an aldehyde or ketone to form silver metal (0):
-
+Ag(NH3)2OH+glucose→Ag0 - The composite material may in incorporated into a variety of systems, materials and compositions, including liquids, solids, gels, coating compositions, cosmetic and pharmaceutical compositions and the like. The composite material may be incorporated into structures or articles of manufacture such as absorbent articles, wound care articles, soft surfaces, or hard surfaces. Compositions containing the composite material may be solutions or dry materials, that are coated, applied, extruded, sprayed, and so forth as further described below. Such compositions may have end uses in manufacturing, commercial, industrial, personal, or domestic applications.
- Systems comprising the composite material can be employed to bring about certain, desired benefits, for example improved fluid absorbency, wettability, strike-through, comfort, malodor control, lubricity, anti-inflammatory properties, anti-microbial properties, anti-fungal properties, modification of surface friction, flexibility, transparency, modulus, tensile strength, color enhancement, viscosity, smoothness, or gel strength.
- In certain embodiments, the presence of the composite material in a composition does not affect the desirable properties of the composition, for example transparency. Addition of the composite material to a liquid composition, for instance, will not alter the transparency or color of the resultant composition as compared to the original, liquid material not containing the composite material. Moreover, since nanoparticles possess large surface areas, the composite material will also allow for higher concentrations of metals to be included in the overall formulation, such as in the treatment of infections.
- Compositions of the invention may comprise the composite material and any other ingredients appropriate for the intended use of the compositions. Some compositions of the invention may comprise: (a) the composite material, which may be an effective amount of the composite material; (b) a suitable carrier medium; and (c) optionally one or more adjunct ingredients. The adjunct ingredients may be, for example, surfactants or charged functionalized molecules exhibiting properties selected from the group consisting of hydrophilic, hydrophobic and mixtures thereof associated with at least some of the composite material, or both.
- Alternatively, an effective amount of composite material described above can be included in compositions useful for coating a variety of soft surfaces in need of treatment. As used herein, an effective amount of composite material refers to the quantity of composite material necessary to impart the desired benefit to the soft surface. Such effective amounts are readily ascertained by one of ordinary skill in the art and is based on many factors, such as the particular composite material used, the nature of the soft surface whether a liquid or dry (e.g., granular, powder) composition is required, and the like.
- The composition may be applied to the surface(s) by washing, spraying, dipping, painting, wiping, or by other manner in order to deliver a coating, especially a transparent coating that covers at least about 0.5% of the surface, or any greater percentage of the surface, including but not limited to: at least about 5%, at least about 10%, at least about 30%, at least about 50%, at least about 80%, and at least about 100% of the surface. Accordingly, the coating may be continuous or discontinuous.
- If the coating composition is to be sprayed onto the surface, the viscosity of the coating composition should be such that it will be capable of passing through the nozzle of a spray device. Such viscosities are well known, and are incorporated herein by reference. The composition may be capable of undergoing shear thinning so that it is capable of being sprayed.
- Suitable carrier mediums for the compositions containing the composite material include liquids, solids and gases. One suitable carrier medium is water, which can be distilled, deionized, or tap water. Water is valuable due to its low cost, availability, safety, and compatibility. The pH of the liquid, in particular water, may be adjusted through the addition of acid or base. Aqueous carrier mediums are also easy apply to a substrate and then dried. Though aqueous carrier mediums are more common than dry, nonaqueous mediums, the composition can exist as a dry powder, granule or tablet or encapsulated complex form.
- Optionally, in addition to or in place of water, the carrier medium can comprise a low molecular weight organic solvent. Preferably, the solvent is highly soluble in water, e.g., ethanol, methanol, propanol, isopropanol, ethylene glycol, acetone, and the like, and mixtures thereof. The solvent can be used at any suitable level. Several non-limiting examples, include a level of up to about 50%, or more; from about 0.1% to about 25%; from about 2% to about 15%, and from about 5% to about 10%, by weight of the total composition. Factors to consider when a high level of solvent is used in the composition are odor, flammability, dispersancy of the nanoparticles and environmental impact.
- The carrier medium may also comprise a film former, which when dried, forms a continuous film. Examples of film formers are polyvinyl alcohol, polyethylene oxide, polypropylene oxide, acrylic emulsions, hydroxypropylmethyl cellulose.
- Adjunct ingredients that may be used in compositions containing the composite material include polymers and copolymers with at least one segment or group which comprises functionality that serves to anchor the composite material to a substrate. These polymers may also comprise at least one segment or group that serves to provide additional character to the polymer, such as hydrophilic or hydrophobic properties.
- Examples of the anchoring segments or groups include: polyamines, quaternized polyamines, amino groups, quaternized amino groups, and corresponding amine oxides; zwitterionic polymers; polycarboxylates; polyethers; polyhydroxylated polymers; polyphosphonates and polyphosphates; and polymeric chelants.
- Examples of the hydrophilizing segments or groups include: ethoxylated or alkoxylated polyamines; polyamines; polycarboxylated polyamines; water soluble polyethers; water soluble polyhydroxylated groups or polymers, including saccharides and polysaccharides; water soluble carboxylates and polycarboxylates; water soluble anionic groups such as carboxylates, sulfonates, sulfates, phosphates, phosphonates and polymers thereof; water soluble amines, quaternaries, amine oxides and polymers thereof; water soluble zwitterionic groups and polymers thereof; water soluble amides and polyamides; and water soluble polymers and copolymers of vinylimidazole and vinylpyrrolidone.
- Examples of the hydrophobizing segments or groups include: alkyl, alkylene, and aryl groups, and polymeric aliphatic or aromatic hydrocarbons; fluorocarbons and polymers comprising fluorocarbons; silicones; hydrophobic polyethers such as poly(styrene oxide), poly(propylene oxide), polybutylene oxide), poly(tetramethylene oxide), and poly(dodecyl glycidyl ether); and hydrophobic polyesters such as polycaprolactone and poly(3-hydroxycarboxylic acids).
- Examples of hydrophilic surface polymers that may be incorporated into the compositions of the invention include, but are not limited to: ethoxylated or alkoxylated polyamines; polycarboxylated polyamines; polycarboxylates including but not limited to polyacrylate; polyethers; polyhydroxyl materials; polyphosphates and phosphonates.
- Examples of hydrophobic surface polymers that may be incorporated into the compositions of the invention include alkylated polyamines include, but are not limited to: polyethyleneimine alkylated with fatty alkylating agents such as dodecyl bromide, octadecyl bromide, oleyl chloride, dodecyl glycidyl ether and benzyl chloride or mixtures thereof; and polyethyleneimine acylated with fatty acylating agents such as methyl dodecanoate and oleoyl chloride; silicones including, but not limited to: polydimethylsiloxane having pendant aminopropyl or aminoethylaminopropyl groups and fluorinated polymers including, but not limited to: polymers including as monomers (meth)acrylate esters of perfluorinated or highly fluorinated alkyl groups.
- Non-polymeric surface modifying materials that may be used as adjunct ingredients include fatty amines and quaternized amines including: ditallowedimethylammonium chloride; octadecyltrimethylammonium bromide; dioleyl amine; and benzyltetradecyldimethylammonium chloride. Silicone-based surfactants, fatty zwitterionic surfactants and fatty amine oxides may also be incorporated into the composition.
- Surfactants are also optional adjunct ingredients. Surfactants are especially useful in the composition as wetting agents to facilitate the dispersion.
- Suitable surfactants can be selected from the group including anionic surfactants, cationic surfactants, nonionic surfactants, amphoteric surfactants, ampholytic surfactants, zwitterionic surfactants and mixtures thereof. Examples of suitable nonionic, anionic, cationic, ampholytic, zwitterionic and semi-polar nonionic surfactants are disclosed in U.S. Pat. Nos. 5,707,950 and 5,576,282. Nonionic surfactants may be characterized by an HLB (hydrophilic-lipophilic balance) of from 5 to 20, alternatively from 6 to 15.
- Mixtures of anionic and nonionic surfactants are especially useful. Other conventional useful surfactants are listed in standard texts.
- Another class of adjunct ingredients that may be useful are silicone surfactants and/or silicones. They can be used alone and/or alternatively in combination with other surfactants described herein above. Nonlimiting examples of silicone surfactants are the polyalkylene oxide polysiloxanes having a dimethyl polysiloxane hydrophobic moiety and one or more hydrophilic polyalkylene side chains
- If used, the surfactant is should be formulated to be compatible with the composite material, carrier medium and other adjunct ingredients present in the composition.
- The compositions can contain other adjunct ingredients, including but not limited to alkalinity sources, antioxidants, anti-static agents, chelating agents, aminocarboxylate chelators, metallic salts, photoactive inorganic metal oxides, odor-controlling materials, perfumes, photoactivators, polymers, preservatives, processing aids, pigments, and pH control agents, solubilizing agents, zeolites, and mixtures thereof. These optional ingredients may be included at any desired level.
- Coating compositions comprising the composite material can be used on all types of soft surfaces, including but not limited to woven fibers, nonwoven fibers, leather, plastic (for example, toothbrush handles, synthetic film, filaments, toothbrush bristles), and mixtures thereof. The soft surfaces of interest herein may comprise any known type of soft surface, including but not limited to those associated with disposable absorbent articles including but not limited to covers or topsheets, absorbent cores, transfer layers, absorbent inserts, and backsheets including those outer layers made from breathable and nonbreathable films.
- It should be understood that in certain embodiments, such a coating composition can be applied to hard surfaces, and provide benefits thereto.
- In certain embodiments, the soft surface may comprise one or more fibers. A fiber is defined as a fine hairlike structure, of vegetable, mineral, or synthetic origin. Commercially available fibers have diameters ranging from less than about 0.001 mm (about 0.00004 in) to more than about 0.2 mm (about 0.008 in) and they come in several different forms: short fibers (known as staple, or chopped), continuous single fibers (filaments or monofilaments), untwisted bundles of continuous filaments (tow), and twisted bundles of continuous filaments (yarn). Fibers are classified according to their origin, chemical structure, or both. They can be braided into ropes and cordage, made into felts (also called nonwovens or nonwoven fabrics), woven or knitted into textile fabrics, or, in the case of high-strength fibers, used as reinforcements in composites-that is, products made of two or more different materials.
- The soft surfaces may comprise fibers made by nature (natural fibers), made by man (synthetic or man-made), or combinations thereof. Example of natural fibers include but are not limited to: animal fibers such as wool, silk, fur, and hair; vegetable fibers such as cellulose, cotton, flax, linen, and hemp; and certain naturally occurring mineral fibers. Synthetic fibers can be derived from natural fibers or not. Examples of synthetic fibers which are derived from natural fibers include but are not limited to rayon and lyocell, both of which are derived from cellulose, a natural polysaccharide fiber. Synthetic fibers which are not derived from natural fibers can be derived from other natural sources or from mineral sources. Example synthetic fibers derived from natural sources include but are not limited to polysaccharides such as starch. Example fibers from mineral sources include but are not limited to polyolefin fibers such as polypropylene and polyethylene fibers, which are derived from petroleum, and silicate fibers such as glass and asbestos. Synthetic fibers are commonly fowled, when possible, by fluid handling processes (e.g., extruding, drawing, or spinning a fluid such as a resin or a solution). Synthetic fibers are also formed by solid handling size reduction processes (e.g., mechanical chopping or cutting of a larger object such as a monolith, a film, or a fabric).
- Disposable absorbent articles, such as pantiliners, sanitary napkins, interlabial devices, adult incontinent devices, breast pads, shoe insoles, bandages, and diapers typically are made from absorbent, nonwoven materials (including fibers) and are well known in the art. These articles typically have a fluid permeable body-facing side and fluid impermeable garment facing side. Additionally, such articles may include an absorbent core for retaining fluids therebetween. Addition of the composite material to an article of manufacture such as the absorbent core of a disposable, absorbent article may help control malodor formation and increase absorbency.
- Other uses for the composite material include but are not limited to use in dental abrasives for toothpaste, odor absorbents, and oral rinses. Other uses for the composite material include ophthalmic solutions and devices such as contact lenses.
- Another embodiment of the invention relates to cosmetic and pharmaceutical compositions comprising the composite material. These may be in the form of creams, lotions, gels, foams, oils, ointments, or powders for application to tissues including skin, hair, nails, and mucosa such as vaginal or oral mucosa. Such compositions may be formulated as either leave-on products or rinse-off products. Alternatively, such compositions may also be in the form of ophthalmic solutions or ointments, which are applied directly to the eye.
- In one embodiment, the composition contains an anti-acne agent such as salicylic acid or benzoyl peroxide.
- In another embodiment, the composition is a personal lubricant such as those disclosed in U.S. Ser. Nos. 10/137,509; 10/390,511; and 10/389,871, filed May 1, 2002; Mar. 17, 2003; Mar. 17, 2003, respectively. These applications describe warming lubricant compositions that are non-toxic and non-irritating and that can be used as personal lubricants designed to come into contact with the skin or mucosa. When mixed with water, such compositions increase in temperature or generate warmth. This has a soothing effect on the tissues to which these compositions are applied. These compositions are preferably substantially anhydrous and preferably contain at least one polyhydric alcohol. By incorporating the composite material into these personal lubrications, the resultant compositions have a smoother characteristic and remain as clear solutions, as the composite material does not detract from the transparency of the compositions.
- Cosmetic and pharmaceutical compositions may contain a variety of active agents known in the art such as skin lightening agents, skin pigmentation darkening agents, anti-acne agents, sebum modulators, shine control agents, anti-microbial agents, anti-fungals, anti-inflammatory agents, anti-mycotic agents, anti-parasite agents, external analgesics, sunscreens, photoprotectors, antioxidants, keratolytic agents, detergents, surfactants, moisturizers, nutrients, vitamins, energy enhancers, anti-perspiration agents, astringents, deodorants, hair removers, firming agents, anti-callous agents, and agents for hair, nail, or skin conditioning.
- Formulations for topical or mucosal application are well known in the art. Excipients used by those skilled in the art in such formulations may be used with the composite material herein, provided they are compatible.
- The compositions of the present invention can be applied to a surface and optionally allowed to dry on the surface, optionally repeating the application and drying steps as needed. In some embodiments of the methods described herein, including, but not limited to when applying more than one coating, it is not necessarily required to dry the coating(s) between applications.
- In order to deposit silver metal on nanoclay, silver ions were reduced in the presence of Laponite using the Tollen's reagent, which is able to undergo reduction by either an aldehyde or ketone to form silver metal via the following reaction:
-
Ag(NH3)2OH+glucose→Ag0 - The Tollen's reagent was prepared by adding two drops of 10% NaOH to 5 mL of 5% AgNO3 to form a gray-brown precipitate. This precipitate was then dissolved by the dropwise addition of 2% NH4OH to yield a total Tollen's reagent volume of 30 mL.
- A solution of silver-loaded Laponite XLS was prepared by adding 600 mg of Laponite XLS to 50 mL of distilled water and using a magnetic stirrer to exfoliate for 20 minutes. To this solution, 800 mg of glucose were added and the stirring continued for 10 minutes to ensure complete dissolution of the glucose. To this, 10 mL of Tollen's reagent as prepared above were added. After two hours of continuous stirring, the solution turned golden yellow in color. Further reaction time yielded a dark amber-brown solution. Samples prepared for particle size analysis and TEM analysis were diluted by a factor of 10 to prevent particle aggregation. The particle size of the nanoparticles dictates the color of the solution caused by a surface plasmon resonance phenomenon. For silver particles, a yellow color has been determined to have the smallest particle size possible. The particle size distribution of the resulting nanoparticles is shown in
FIG. 1 . - The formation of silver metal from silver ions was also investigated using NaBH4:
-
4AgNO3+NaBH4→4Ag0 - Dropwise addition of 32 mg of AgNO3 dissolved in 5 mL of H2O to a solution containing 500 mg of exfoliated Laponite XLS and 4 mg NaBH4 yielded a golden yellow solution. This addition order for this particular reaction was determined to give the smallest particle size.
- Nanoparticles of silver-laponite were prepared by reduction with sodium citrate, although the reduction by this method was more difficult to control. Citric acid was added to an exfoliated Laponite XLS solution, followed by the addition of silver nitrate. 10% NaOH was added dropwise to form the sodium salt of citric acid until the solution turned faintly yellow. In many cases, the over-addition of sodium hydroxide caused the silver particles to fall out of solution.
-
AgNO3+sodium citrate→Ag0 - Nanoparticles of silver-loaded Laponite XLS can be prepared by hydrazine reduction as follows: 5 g of Laponite XLS are added to 995 g of deionized water and stirred for 20 minutes to exfoliate the Laponite XLS. 20 mg of 55% hydrazine hydrate is added to the Laponite XLS dispersion and the solution is stirred for 1 minute. 77 mg of AgNO3 is dissolved in deionized water. The AgNO3 solution is added dropwise to the Laponite—hydrazine solution to form a golden-yellow solution containing 0.005% silver-loaded Laponite XLS.
- Another solution of silver-loaded Laponite XLS was prepared similarly to Example 1, but the order of the components was altered. Glucose and Tollen's reagent were mixed in a separate vessel and once the color of the solution turned faintly gray, this mixture was added to the solution of exfoliated Laponite XLS. After a short period of stirring, the solution turned amber-yellow. This solution was diluted by a factor of 10 for particle size analysis. The particle size distribution of the resulting material is shown in
FIG. 2 . - A sample was prepared by adding 200 mg of Laponite XLS to 100 mL of water and stirring to exfoliate. The sample was analyzed for particle size. The results are shown in
FIG. 3 . - The sample of Example 6 was diluted by a factor of 50. The sample was analyzed for particle size. The results are shown in
FIG. 4 . - The results of Examples 1-7 indicate that as a solution of Laponite XLS in water is diluted, the distribution of particle sizes changes. The particle size of silver-loaded Laponite XLS was smaller, on average, than Laponite XLS alone, indicating that the addition of silver to the solution aided in the Laponite XLS exfoliation process.
- The data for Example 1 shows a single particle size distribution, averaging 4.1 nm in size. Example 5, on the other hand, showed a bimodal particle size distribution with the averages centered on 4.1 nm and 11 nm. This indicates the formation of two different types of particles. It is possible that this solution contained silver-loaded Laponite XLS and colloidal silver with no Laponite core.
- To verify that the Laponite XLS was being coated with silver, TEM (transmission electron microscopic) images and EDX (Energy Dispersive X-Ray) analysis were performed on Examples 1 and 6. The data confirmed that the composite material of Example 1 contained silver-loaded Laponite XLS particles, as opposed to a mixture of colloidal silver and Laponite XLS. Elemental analysis showed the presence of Na, Mg, Si, and Ag (Cu was present in the TEM grid). The data also revealed that particles of very small size (≈1 nm), determined to be uncoated Laponite XLS, were also present.
- A solution containing silver-loaded Laponite XLS particles was prepared as follows. 4.51 g of Laponite XLS was added to 900 mL of deionized water. The solution was stirred for 1 hour and labeled Solution A. To 400 mL of Solution A, 15 mg of NaBH4 was added. This solution was labeled Solution B. 124 mg of AgNO3 was dissolved in 5 mL of deionized water; and this was added dropwise to Solution B to form an amber brown solution of 0.02% silver loaded onto Laponite XLS. Following the above procedure, 0.01%, 0.005% and 0.0025% silver loaded Laponite XLS solutions were prepared. These solutions were analyzed for biocidal activity against the organisms Staphylococcus aureus and Escherichia coli as follows. The silver-loaded Laponite XLS solutions were inoculated with the bacteria and neutralized with Letheen Broth containing 1.5% to neutralize the activity after the appropriate time. Aliquots were plated using Letheen Agar. The bacterial log reduction is given in the Table below.
-
S.a. - S.a. - E.c. - E.c. - Sample Conc. 5 minute 10 min 5 minutes 10 min. 0.0025% 0.8 2.2 3.2 5.3 0.005% 4.8 4.8 5.3 5.3 0.01% 2.2 4.8 5.3 5.3 0.02% 4.8 4.8 5.3 5.3
Claims (8)
1-8. (canceled)
9. A solid comprising the composite material of claim 30 .
10. A gel comprising the composite material of claim 30 .
11-29. (canceled)
30. A composite material comprising (a) an exfoliated nanoparticle comprising synthetic hectorite having a surface and a largest dimension of about 1 to 1000 nm, and (b) silver in the neutral (0) metal state, wherein the silver is loaded onto the surface of the exfoliated nanoparticle.
31. A solution comprising a solvent and 0.0025 to 0.02 weight % of a composite material comprising (a) an exfoliated nanoparticle comprising synthetic hectorite having a surface and a largest dimension of about 1 to 1000 nm, and (b) silver in the neutral (0) metal state, wherein the silver is loaded onto the surface of the exfoliated nanoparticle.
32. The solution of claim 31 , wherein the solvent comprises water.
33. The solution of claim 31 , wherein the solvent comprises an organic solvent selected from the group consisting of ethanol, methanol, propanol, isopropanol, ethylene glycol, acetone and mixtures thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/792,478 US20130189334A1 (en) | 2003-10-30 | 2013-03-11 | Enhancing properties by the use of nanoparticles |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51575803P | 2003-10-30 | 2003-10-30 | |
US10/979,365 US20050175649A1 (en) | 2003-10-30 | 2004-11-01 | Enhancing properties by the use of nanoparticles |
US13/792,478 US20130189334A1 (en) | 2003-10-30 | 2013-03-11 | Enhancing properties by the use of nanoparticles |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/979,365 Continuation US20050175649A1 (en) | 2003-10-30 | 2004-11-01 | Enhancing properties by the use of nanoparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130189334A1 true US20130189334A1 (en) | 2013-07-25 |
Family
ID=34549441
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/979,365 Abandoned US20050175649A1 (en) | 2003-10-30 | 2004-11-01 | Enhancing properties by the use of nanoparticles |
US10/979,364 Expired - Fee Related US7988779B2 (en) | 2003-10-30 | 2004-11-01 | Absorbent articles comprising nanoparticles |
US13/792,478 Abandoned US20130189334A1 (en) | 2003-10-30 | 2013-03-11 | Enhancing properties by the use of nanoparticles |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/979,365 Abandoned US20050175649A1 (en) | 2003-10-30 | 2004-11-01 | Enhancing properties by the use of nanoparticles |
US10/979,364 Expired - Fee Related US7988779B2 (en) | 2003-10-30 | 2004-11-01 | Absorbent articles comprising nanoparticles |
Country Status (11)
Country | Link |
---|---|
US (3) | US20050175649A1 (en) |
EP (2) | EP1682193B1 (en) |
JP (2) | JP2007519615A (en) |
CN (2) | CN1925879B (en) |
AT (2) | ATE405300T1 (en) |
AU (2) | AU2004285578B2 (en) |
BR (2) | BRPI0416114A (en) |
CA (2) | CA2544119C (en) |
DE (2) | DE602004015134D1 (en) |
ES (1) | ES2311879T3 (en) |
WO (2) | WO2005042041A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9624973B2 (en) * | 2012-03-19 | 2017-04-18 | Samsung Electronics Co., Ltd. | Apparatus having friction preventing function and method of manufacturing the same |
WO2020065540A1 (en) * | 2018-09-25 | 2020-04-02 | Church & Dwight Co., Inc. | Animal litters exhibiting enhanced odor reduction properties, and related methods |
US11337421B2 (en) * | 2019-12-24 | 2022-05-24 | Hamed Ahari | Method for producing antimicrobial nanofilms packaging cover based on Titanium nano-dioxide through extrusion for extension of food shelf-life |
Families Citing this family (585)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA04002708A (en) * | 2001-09-24 | 2004-07-05 | Procter & Gamble | Cleaning composition. |
US9060770B2 (en) | 2003-05-20 | 2015-06-23 | Ethicon Endo-Surgery, Inc. | Robotically-driven surgical instrument with E-beam driver |
US20070084897A1 (en) | 2003-05-20 | 2007-04-19 | Shelton Frederick E Iv | Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism |
US8734421B2 (en) | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
US11998198B2 (en) | 2004-07-28 | 2024-06-04 | Cilag Gmbh International | Surgical stapling instrument incorporating a two-piece E-beam firing mechanism |
US9072535B2 (en) | 2011-05-27 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments with rotatable staple deployment arrangements |
US11896225B2 (en) | 2004-07-28 | 2024-02-13 | Cilag Gmbh International | Staple cartridge comprising a pan |
US8215531B2 (en) | 2004-07-28 | 2012-07-10 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument having a medical substance dispenser |
US20060029567A1 (en) * | 2004-08-04 | 2006-02-09 | Bki Holding Corporation | Material for odor control |
JP5082189B2 (en) * | 2005-01-14 | 2012-11-28 | 大日本印刷株式会社 | Coating liquid, metal oxide film and method for forming the same |
EP1888698A4 (en) * | 2005-05-25 | 2010-02-24 | Posco Co Ltd | Ag-containing solution, antibacterial resin composition comprising the solution and antibacterial resin coated steel plate |
FR2889649A1 (en) * | 2005-08-11 | 2007-02-16 | Eastman Kodak Co | Use of a dispersion of silver in imogolite and/or allophane matrix as antiseptic agent for the manufacture of bandages |
US11246590B2 (en) | 2005-08-31 | 2022-02-15 | Cilag Gmbh International | Staple cartridge including staple drivers having different unfired heights |
US10159482B2 (en) | 2005-08-31 | 2018-12-25 | Ethicon Llc | Fastener cartridge assembly comprising a fixed anvil and different staple heights |
US7673781B2 (en) | 2005-08-31 | 2010-03-09 | Ethicon Endo-Surgery, Inc. | Surgical stapling device with staple driver that supports multiple wire diameter staples |
US7934630B2 (en) | 2005-08-31 | 2011-05-03 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US7669746B2 (en) | 2005-08-31 | 2010-03-02 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US11484312B2 (en) | 2005-08-31 | 2022-11-01 | Cilag Gmbh International | Staple cartridge comprising a staple driver arrangement |
US9237891B2 (en) | 2005-08-31 | 2016-01-19 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical stapling devices that produce formed staples having different lengths |
EP1762352A1 (en) * | 2005-09-12 | 2007-03-14 | Nederlandse Organisatie voor Toegepast-Natuuurwetenschappelijk Onderzoek TNO | Method for incorporating a functional additive within a porous material |
US20070106317A1 (en) | 2005-11-09 | 2007-05-10 | Shelton Frederick E Iv | Hydraulically and electrically actuated articulation joints for surgical instruments |
DE202005019670U1 (en) | 2005-12-14 | 2006-04-27 | Riesinger, Birgit | Wound treatment device with elastically deformable negative pressure generating element |
US11278279B2 (en) | 2006-01-31 | 2022-03-22 | Cilag Gmbh International | Surgical instrument assembly |
US20110295295A1 (en) | 2006-01-31 | 2011-12-01 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical instrument having recording capabilities |
US11793518B2 (en) | 2006-01-31 | 2023-10-24 | Cilag Gmbh International | Powered surgical instruments with firing system lockout arrangements |
US11224427B2 (en) | 2006-01-31 | 2022-01-18 | Cilag Gmbh International | Surgical stapling system including a console and retraction assembly |
US8820603B2 (en) | 2006-01-31 | 2014-09-02 | Ethicon Endo-Surgery, Inc. | Accessing data stored in a memory of a surgical instrument |
US20110024477A1 (en) | 2009-02-06 | 2011-02-03 | Hall Steven G | Driven Surgical Stapler Improvements |
US9861359B2 (en) | 2006-01-31 | 2018-01-09 | Ethicon Llc | Powered surgical instruments with firing system lockout arrangements |
US8708213B2 (en) | 2006-01-31 | 2014-04-29 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a feedback system |
US8186555B2 (en) | 2006-01-31 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting and fastening instrument with mechanical closure system |
US20120292367A1 (en) | 2006-01-31 | 2012-11-22 | Ethicon Endo-Surgery, Inc. | Robotically-controlled end effector |
US7845537B2 (en) | 2006-01-31 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Surgical instrument having recording capabilities |
US7753904B2 (en) | 2006-01-31 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Endoscopic surgical instrument with a handle that can articulate with respect to the shaft |
JP2007223917A (en) * | 2006-02-21 | 2007-09-06 | Nippon Chem Ind Co Ltd | Antimicrobial agent |
US8992422B2 (en) | 2006-03-23 | 2015-03-31 | Ethicon Endo-Surgery, Inc. | Robotically-controlled endoscopic accessory channel |
US20070225562A1 (en) | 2006-03-23 | 2007-09-27 | Ethicon Endo-Surgery, Inc. | Articulating endoscopic accessory channel |
AU2006342738B2 (en) * | 2006-04-24 | 2012-06-28 | Ntc S.R.L. | Functional nanomaterials with antibacterial and antiviral activity |
WO2007124800A1 (en) * | 2006-05-03 | 2007-11-08 | Carl Freudenberg Kg | Antimicrobial layer and the use of this layer |
EP1852497A1 (en) * | 2006-05-03 | 2007-11-07 | Carl Freudenberg KG | Antimicrobial layer and use thereof |
ES2349262T3 (en) | 2006-06-14 | 2010-12-29 | Nm Tech Ltd. Nanomaterials And Microdevices Technology | NANOMATERIAL COATINGS FOR OSTEOINTEGRATED BIOMEDICAL PROSTHESIS. |
US8322455B2 (en) | 2006-06-27 | 2012-12-04 | Ethicon Endo-Surgery, Inc. | Manually driven surgical cutting and fastening instrument |
US8232221B2 (en) * | 2006-07-14 | 2012-07-31 | Governors Of The University Of Alberta | Zeolite supported metallic nanodots |
US20080011163A1 (en) * | 2006-07-17 | 2008-01-17 | Mcclain Michael S | Sorbent porous polymeric composite materials |
WO2008045022A2 (en) * | 2006-08-09 | 2008-04-17 | Luna Innovations Incorporated | Additive particles having superhydrophobic characteristics and coatings and methods of making and using the same |
US8202614B2 (en) * | 2006-08-09 | 2012-06-19 | Luna Innovations Incorporated | Additive particles having superhydrophobic characteristics and coatings and methods of making and using the same |
US20080058738A1 (en) * | 2006-08-31 | 2008-03-06 | Kimberly-Clark Worldwide, Inc. | Derivatized expanded starch for odor control |
US20080058739A1 (en) * | 2006-08-31 | 2008-03-06 | Kimberly-Clark Worldwide, Inc. | Expanded starch for odor control |
US7665647B2 (en) | 2006-09-29 | 2010-02-23 | Ethicon Endo-Surgery, Inc. | Surgical cutting and stapling device with closure apparatus for limiting maximum tissue compression force |
US10568652B2 (en) | 2006-09-29 | 2020-02-25 | Ethicon Llc | Surgical staples having attached drivers of different heights and stapling instruments for deploying the same |
US10130359B2 (en) | 2006-09-29 | 2018-11-20 | Ethicon Llc | Method for forming a staple |
US11980366B2 (en) | 2006-10-03 | 2024-05-14 | Cilag Gmbh International | Surgical instrument |
US7632425B1 (en) * | 2006-10-06 | 2009-12-15 | General Electric Company | Composition and associated method |
US20080085962A1 (en) * | 2006-10-06 | 2008-04-10 | General Electric Company | Composition and associated method |
US20080085410A1 (en) * | 2006-10-06 | 2008-04-10 | General Electric Company | Composition and associated method |
EP2079302B1 (en) * | 2006-10-12 | 2014-03-26 | NM Tech Nanomaterials Microdevice Technology, Ltd. | Use of a composition having anti-microbial properties |
AU2013206359A1 (en) * | 2006-10-30 | 2013-07-04 | Mcneil-Ppc, Inc. | Cover material for an absorbent article including a skin care composition and an absorbent article having a cover material including a skin care composition |
US8778817B2 (en) * | 2006-10-30 | 2014-07-15 | Mcneil-Ppc, Inc. | Method of making a cover material including a skin care composition |
US20080103459A1 (en) * | 2006-10-30 | 2008-05-01 | Anthony Di Salvo | Enzyme inhibition using nanoparticles |
US8092814B2 (en) | 2006-10-30 | 2012-01-10 | Mcneil-Ppc, Inc. | Cover material for an absorbent article including a skin care composition and an absorbent article having a cover material including a skin care composition |
FR2908427B1 (en) * | 2006-11-15 | 2009-12-25 | Skin Up | PROCESS FOR IMPREGNATING FIBERS AND / OR TEXTILES WITH A COMPOUND OF INTEREST AND / OR AN ACTIVE INGREDIENT IN THE FORM OF NANOPARTICLES |
CN101611194B (en) * | 2006-11-16 | 2013-08-21 | 多种吸附技术公司 | Clean, compressed sorbent tablets |
WO2008136866A2 (en) * | 2006-11-27 | 2008-11-13 | Micropyretics Heaters International, Inc. | Antimicrobal materials and coatings |
US11291441B2 (en) | 2007-01-10 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with wireless communication between control unit and remote sensor |
US8840603B2 (en) | 2007-01-10 | 2014-09-23 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between control unit and sensor transponders |
US8684253B2 (en) | 2007-01-10 | 2014-04-01 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor |
US8652120B2 (en) | 2007-01-10 | 2014-02-18 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between control unit and sensor transponders |
US11039836B2 (en) | 2007-01-11 | 2021-06-22 | Cilag Gmbh International | Staple cartridge for use with a surgical stapling instrument |
US20080169333A1 (en) | 2007-01-11 | 2008-07-17 | Shelton Frederick E | Surgical stapler end effector with tapered distal end |
US20100196294A1 (en) * | 2007-01-26 | 2010-08-05 | Coty Inc. | Coatings for mammalian nails that include nanosized particles |
US7669747B2 (en) | 2007-03-15 | 2010-03-02 | Ethicon Endo-Surgery, Inc. | Washer for use with a surgical stapling instrument |
US20080229612A1 (en) * | 2007-03-22 | 2008-09-25 | Poshpeds Incorporated | Human wearable laminar structure, insole made therefrom and methods for their manufacture |
US8893946B2 (en) | 2007-03-28 | 2014-11-25 | Ethicon Endo-Surgery, Inc. | Laparoscopic tissue thickness and clamp load measuring devices |
CA2682757C (en) * | 2007-04-04 | 2014-05-27 | Perlen Converting Ag | Antimicrobial material |
US11564682B2 (en) | 2007-06-04 | 2023-01-31 | Cilag Gmbh International | Surgical stapler device |
US8931682B2 (en) | 2007-06-04 | 2015-01-13 | Ethicon Endo-Surgery, Inc. | Robotically-controlled shaft based rotary drive systems for surgical instruments |
US7753245B2 (en) | 2007-06-22 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments |
US8308040B2 (en) | 2007-06-22 | 2012-11-13 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument with an articulatable end effector |
US11849941B2 (en) | 2007-06-29 | 2023-12-26 | Cilag Gmbh International | Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis |
CN101861155A (en) | 2007-09-28 | 2010-10-13 | 强生消费者公司 | Electricity-generating particulates and the use thereof |
KR20090034620A (en) * | 2007-10-04 | 2009-04-08 | 광주과학기술원 | Gold nanopaticle-halloysite nanotube and method of forming the same |
ES2319064B1 (en) * | 2007-10-05 | 2010-02-15 | Universidad De Santiago De Compostela | USE OF ATOMIC QUANTIC CLUSTERS (AQCS) AS ANTIMICROBIALS AND BIOCIDES. |
US20090104434A1 (en) * | 2007-10-17 | 2009-04-23 | Jennifer Hoyt Lalli | Conformal multifunctional coatings |
US20090148484A1 (en) * | 2007-12-07 | 2009-06-11 | National Taiwan University | Stably-dispersing composite of metal nanoparticle and inorganic clay and method for producing the same |
JP4561837B2 (en) * | 2008-01-07 | 2010-10-13 | 日本電気株式会社 | REPRODUCTION DEVICE, SYSTEM, METHOD, PROGRAM, AND COMPUTER-READABLE RECORDING MEDIUM |
GB2457294A (en) * | 2008-02-08 | 2009-08-12 | Sun Chemical Ltd | Oxygen barrier coating composition |
US8561870B2 (en) | 2008-02-13 | 2013-10-22 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument |
US8758391B2 (en) | 2008-02-14 | 2014-06-24 | Ethicon Endo-Surgery, Inc. | Interchangeable tools for surgical instruments |
US7819298B2 (en) | 2008-02-14 | 2010-10-26 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with control features operable with one hand |
US7866527B2 (en) | 2008-02-14 | 2011-01-11 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with interlockable firing system |
US11986183B2 (en) | 2008-02-14 | 2024-05-21 | Cilag Gmbh International | Surgical cutting and fastening instrument comprising a plurality of sensors to measure an electrical parameter |
US8573465B2 (en) | 2008-02-14 | 2013-11-05 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical end effector system with rotary actuated closure systems |
US8636736B2 (en) | 2008-02-14 | 2014-01-28 | Ethicon Endo-Surgery, Inc. | Motorized surgical cutting and fastening instrument |
US9179912B2 (en) | 2008-02-14 | 2015-11-10 | Ethicon Endo-Surgery, Inc. | Robotically-controlled motorized surgical cutting and fastening instrument |
RU2493788C2 (en) | 2008-02-14 | 2013-09-27 | Этикон Эндо-Серджери, Инк. | Surgical cutting and fixing instrument, which has radio-frequency electrodes |
US8657174B2 (en) | 2008-02-14 | 2014-02-25 | Ethicon Endo-Surgery, Inc. | Motorized surgical cutting and fastening instrument having handle based power source |
US11272927B2 (en) | 2008-02-15 | 2022-03-15 | Cilag Gmbh International | Layer arrangements for surgical staple cartridges |
US10390823B2 (en) | 2008-02-15 | 2019-08-27 | Ethicon Llc | End effector comprising an adjunct |
US20090206131A1 (en) | 2008-02-15 | 2009-08-20 | Ethicon Endo-Surgery, Inc. | End effector coupling arrangements for a surgical cutting and stapling instrument |
US9821105B2 (en) | 2008-07-01 | 2017-11-21 | Baxter International Inc. | Nanoclay sorbents for dialysis |
US7832612B2 (en) | 2008-09-19 | 2010-11-16 | Ethicon Endo-Surgery, Inc. | Lockout arrangement for a surgical stapler |
PL3476312T3 (en) | 2008-09-19 | 2024-03-11 | Ethicon Llc | Surgical stapler with apparatus for adjusting staple height |
US11648005B2 (en) | 2008-09-23 | 2023-05-16 | Cilag Gmbh International | Robotically-controlled motorized surgical instrument with an end effector |
US8210411B2 (en) | 2008-09-23 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument |
US9386983B2 (en) | 2008-09-23 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Robotically-controlled motorized surgical instrument |
US9005230B2 (en) | 2008-09-23 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Motorized surgical instrument |
US8608045B2 (en) | 2008-10-10 | 2013-12-17 | Ethicon Endo-Sugery, Inc. | Powered surgical cutting and stapling apparatus with manually retractable firing system |
US8517239B2 (en) | 2009-02-05 | 2013-08-27 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument comprising a magnetic element driver |
US8444036B2 (en) | 2009-02-06 | 2013-05-21 | Ethicon Endo-Surgery, Inc. | Motor driven surgical fastener device with mechanisms for adjusting a tissue gap within the end effector |
US8453907B2 (en) | 2009-02-06 | 2013-06-04 | Ethicon Endo-Surgery, Inc. | Motor driven surgical fastener device with cutting member reversing mechanism |
BRPI1008667A2 (en) | 2009-02-06 | 2016-03-08 | Ethicom Endo Surgery Inc | improvement of the operated surgical stapler |
US20120089232A1 (en) | 2009-03-27 | 2012-04-12 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
US20110060419A1 (en) | 2009-03-27 | 2011-03-10 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
JP2012521804A (en) | 2009-03-27 | 2012-09-20 | アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー | Medical devices with galvanic particulates |
US20100268335A1 (en) | 2009-03-27 | 2010-10-21 | Chunlin Yang | Medical devices with galvanic particulates |
JP2012522002A (en) * | 2009-03-27 | 2012-09-20 | ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド | Binary and ternary galvanic particulates and methods and uses thereof |
TW201102363A (en) * | 2009-07-01 | 2011-01-16 | Univ Nat Taiwan | Polymeric polymer including poly(oxyethylene)-amine and method for producing silver nanoparticle by employing the same |
RU2404301C1 (en) * | 2009-09-24 | 2010-11-20 | Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО "ИПН") | Method of thread processing |
RU2429820C2 (en) * | 2009-09-24 | 2011-09-27 | Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО"ИПН") | Antiseptic ointment for outward application (2 versions) |
FR2952306B1 (en) * | 2009-11-09 | 2012-03-30 | Creaspine | AQUEOUS COMPOSITION FOR THE TREATMENT OF LASER FIBROUS CONJUNCTIVE TISSUE REPAIR |
US8851354B2 (en) | 2009-12-24 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Surgical cutting instrument that analyzes tissue thickness |
US8220688B2 (en) | 2009-12-24 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument with electric actuator directional control assembly |
US8608046B2 (en) | 2010-01-07 | 2013-12-17 | Ethicon Endo-Surgery, Inc. | Test device for a surgical tool |
KR20110091461A (en) | 2010-02-05 | 2011-08-11 | 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 | Lip compositions comprising galvanic particulates |
CN102781406B (en) | 2010-03-01 | 2015-07-08 | 强生消费者公司 | Skin care composition having desirable bulk color |
RU2419455C1 (en) * | 2010-03-03 | 2011-05-27 | Закрытое акционерное общество "Институт прикладной нанотехнологии" | Hygienic product with antimicrobial and antifungal properties |
RU2431656C1 (en) * | 2010-04-20 | 2011-10-20 | Закрытое акционерное общество "Институт прикладной нанотехнологии" | Toilet soap with antimicrobial properties |
RU2426560C1 (en) * | 2010-06-21 | 2011-08-20 | Закрытое акционерное общество "Институт прикладной нанотехнологии" | Composition for antiseptic processing woven materials |
US8822386B2 (en) | 2010-06-28 | 2014-09-02 | Baker Hughes Incorporated | Nanofluids and methods of use for drilling and completion fluids |
KR20140003378A (en) | 2010-07-08 | 2014-01-09 | 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 | Skin care emulsion composition |
US8783543B2 (en) | 2010-07-30 | 2014-07-22 | Ethicon Endo-Surgery, Inc. | Tissue acquisition arrangements and methods for surgical stapling devices |
WO2012027728A2 (en) | 2010-08-27 | 2012-03-01 | Sienna Labs, Inc. | Compositions and methods for targeted thermomodulation |
US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
RU2426525C1 (en) * | 2010-08-31 | 2011-08-20 | Закрытое акционерное общество "Институт прикладной нанотехнологии" | Preventive ointment for diabetic foot |
US8360296B2 (en) | 2010-09-09 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Surgical stapling head assembly with firing lockout for a surgical stapler |
US9289212B2 (en) | 2010-09-17 | 2016-03-22 | Ethicon Endo-Surgery, Inc. | Surgical instruments and batteries for surgical instruments |
US8632525B2 (en) | 2010-09-17 | 2014-01-21 | Ethicon Endo-Surgery, Inc. | Power control arrangements for surgical instruments and batteries |
US8733613B2 (en) | 2010-09-29 | 2014-05-27 | Ethicon Endo-Surgery, Inc. | Staple cartridge |
US20120080498A1 (en) | 2010-09-30 | 2012-04-05 | Ethicon Endo-Surgery, Inc. | Curved end effector for a stapling instrument |
US9204880B2 (en) | 2012-03-28 | 2015-12-08 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator comprising capsules defining a low pressure environment |
BR112013007717B1 (en) | 2010-09-30 | 2020-09-24 | Ethicon Endo-Surgery, Inc. | SURGICAL CLAMPING SYSTEM |
US9332974B2 (en) | 2010-09-30 | 2016-05-10 | Ethicon Endo-Surgery, Llc | Layered tissue thickness compensator |
US9517063B2 (en) | 2012-03-28 | 2016-12-13 | Ethicon Endo-Surgery, Llc | Movable member for use with a tissue thickness compensator |
US9364233B2 (en) | 2010-09-30 | 2016-06-14 | Ethicon Endo-Surgery, Llc | Tissue thickness compensators for circular surgical staplers |
US9307989B2 (en) | 2012-03-28 | 2016-04-12 | Ethicon Endo-Surgery, Llc | Tissue stapler having a thickness compensator incorportating a hydrophobic agent |
US9592050B2 (en) | 2010-09-30 | 2017-03-14 | Ethicon Endo-Surgery, Llc | End effector comprising a distal tissue abutment member |
US9629814B2 (en) | 2010-09-30 | 2017-04-25 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator configured to redistribute compressive forces |
US10945731B2 (en) | 2010-09-30 | 2021-03-16 | Ethicon Llc | Tissue thickness compensator comprising controlled release and expansion |
US9301755B2 (en) | 2010-09-30 | 2016-04-05 | Ethicon Endo-Surgery, Llc | Compressible staple cartridge assembly |
US9301752B2 (en) | 2010-09-30 | 2016-04-05 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator comprising a plurality of capsules |
US9386988B2 (en) | 2010-09-30 | 2016-07-12 | Ethicon End-Surgery, LLC | Retainer assembly including a tissue thickness compensator |
US9351730B2 (en) | 2011-04-29 | 2016-05-31 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator comprising channels |
US11812965B2 (en) | 2010-09-30 | 2023-11-14 | Cilag Gmbh International | Layer of material for a surgical end effector |
US9314246B2 (en) | 2010-09-30 | 2016-04-19 | Ethicon Endo-Surgery, Llc | Tissue stapler having a thickness compensator incorporating an anti-inflammatory agent |
US9220501B2 (en) | 2010-09-30 | 2015-12-29 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensators |
US11298125B2 (en) | 2010-09-30 | 2022-04-12 | Cilag Gmbh International | Tissue stapler having a thickness compensator |
US9480476B2 (en) | 2010-09-30 | 2016-11-01 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator comprising resilient members |
US11849952B2 (en) | 2010-09-30 | 2023-12-26 | Cilag Gmbh International | Staple cartridge comprising staples positioned within a compressible portion thereof |
US8695866B2 (en) | 2010-10-01 | 2014-04-15 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a power control circuit |
EP2461655A1 (en) * | 2010-12-06 | 2012-06-06 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | Hybrid materials for printing conductive or semiconductive elements |
US20120231251A1 (en) * | 2011-03-09 | 2012-09-13 | Samsung Electronics Co., Ltd. | Composition for clay-aerogel composite, clay-aerogel composite, and method of making the same |
US9113883B2 (en) | 2011-03-14 | 2015-08-25 | Ethicon Endo-Surgery, Inc. | Collapsible anvil plate assemblies for circular surgical stapling devices |
BR112013027794B1 (en) | 2011-04-29 | 2020-12-15 | Ethicon Endo-Surgery, Inc | CLAMP CARTRIDGE SET |
US11207064B2 (en) | 2011-05-27 | 2021-12-28 | Cilag Gmbh International | Automated end effector component reloading system for use with a robotic system |
KR101333209B1 (en) | 2011-06-17 | 2013-11-26 | 부산대학교 산학협력단 | Cosmetic composition for preventing skin aging comprising surface-modified gold nanoparticle by phytochemical |
WO2013026879A1 (en) * | 2011-08-23 | 2013-02-28 | Birgit Riesinger | Absorbent hygienic or personal care product having a strip-like component with a content of at least one heavy metal present in elemental or ionic form |
US9050084B2 (en) | 2011-09-23 | 2015-06-09 | Ethicon Endo-Surgery, Inc. | Staple cartridge including collapsible deck arrangement |
WO2013044202A1 (en) * | 2011-09-25 | 2013-03-28 | Waukesha Electric Systems, Inc. | Insulation for power transformers |
US9028851B2 (en) | 2011-12-21 | 2015-05-12 | Ethicon, Inc. | Hemostatic materials and devices with galvanic particulates |
US9044230B2 (en) | 2012-02-13 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status |
JP5924807B2 (en) * | 2012-02-14 | 2016-05-25 | 日本フイルコン株式会社 | Gel-like metal adsorbent and gel-like metal adsorbent-carrying adsorbent |
US9386816B2 (en) | 2012-02-14 | 2016-07-12 | International Textile Group, Inc. | Fire resistant garments containing a high lubricity thermal liner |
US8784773B2 (en) * | 2012-02-25 | 2014-07-22 | Mohammad Mojmeli Renani | Hydrogel nanocomposite wound dressing and a method of synthesizing the same |
US9078653B2 (en) | 2012-03-26 | 2015-07-14 | Ethicon Endo-Surgery, Inc. | Surgical stapling device with lockout system for preventing actuation in the absence of an installed staple cartridge |
US9198662B2 (en) | 2012-03-28 | 2015-12-01 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator having improved visibility |
RU2014143258A (en) | 2012-03-28 | 2016-05-20 | Этикон Эндо-Серджери, Инк. | FABRIC THICKNESS COMPENSATOR CONTAINING MANY LAYERS |
BR112014024194B1 (en) | 2012-03-28 | 2022-03-03 | Ethicon Endo-Surgery, Inc | STAPLER CARTRIDGE SET FOR A SURGICAL STAPLER |
CN104334098B (en) | 2012-03-28 | 2017-03-22 | 伊西康内外科公司 | Tissue thickness compensator comprising capsules defining a low pressure environment |
EP2837035A2 (en) | 2012-04-12 | 2015-02-18 | Sol Voltaics AB | Methods of nanowire functionalization, dispersion and attachment |
WO2013169955A1 (en) | 2012-05-08 | 2013-11-14 | The Regents Of The University Of California | Fine spatiotemporal control of thermolysis and lipolysis using nir light |
US9522289B2 (en) | 2012-05-08 | 2016-12-20 | The Regents Of The University Of California | Selective fat removal using photothermal heating |
US9101358B2 (en) | 2012-06-15 | 2015-08-11 | Ethicon Endo-Surgery, Inc. | Articulatable surgical instrument comprising a firing drive |
US9028494B2 (en) | 2012-06-28 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Interchangeable end effector coupling arrangement |
RU2636861C2 (en) | 2012-06-28 | 2017-11-28 | Этикон Эндо-Серджери, Инк. | Blocking of empty cassette with clips |
US9226751B2 (en) | 2012-06-28 | 2016-01-05 | Ethicon Endo-Surgery, Inc. | Surgical instrument system including replaceable end effectors |
US9125662B2 (en) | 2012-06-28 | 2015-09-08 | Ethicon Endo-Surgery, Inc. | Multi-axis articulating and rotating surgical tools |
US20140001231A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Firing system lockout arrangements for surgical instruments |
US11197671B2 (en) | 2012-06-28 | 2021-12-14 | Cilag Gmbh International | Stapling assembly comprising a lockout |
BR112014032776B1 (en) | 2012-06-28 | 2021-09-08 | Ethicon Endo-Surgery, Inc | SURGICAL INSTRUMENT SYSTEM AND SURGICAL KIT FOR USE WITH A SURGICAL INSTRUMENT SYSTEM |
US9561038B2 (en) | 2012-06-28 | 2017-02-07 | Ethicon Endo-Surgery, Llc | Interchangeable clip applier |
US9119657B2 (en) | 2012-06-28 | 2015-09-01 | Ethicon Endo-Surgery, Inc. | Rotary actuatable closure arrangement for surgical end effector |
US9101385B2 (en) | 2012-06-28 | 2015-08-11 | Ethicon Endo-Surgery, Inc. | Electrode connections for rotary driven surgical tools |
US9282974B2 (en) | 2012-06-28 | 2016-03-15 | Ethicon Endo-Surgery, Llc | Empty clip cartridge lockout |
US9072536B2 (en) | 2012-06-28 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Differential locking arrangements for rotary powered surgical instruments |
US9289256B2 (en) | 2012-06-28 | 2016-03-22 | Ethicon Endo-Surgery, Llc | Surgical end effectors having angled tissue-contacting surfaces |
US9204879B2 (en) | 2012-06-28 | 2015-12-08 | Ethicon Endo-Surgery, Inc. | Flexible drive member |
EP3272388A1 (en) | 2012-10-11 | 2018-01-24 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
US9386985B2 (en) | 2012-10-15 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Surgical cutting instrument |
US9394637B2 (en) | 2012-12-13 | 2016-07-19 | Jacob Holm & Sons Ag | Method for production of a hydroentangled airlaid web and products obtained therefrom |
US9386984B2 (en) | 2013-02-08 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Staple cartridge comprising a releasable cover |
RU2669463C2 (en) | 2013-03-01 | 2018-10-11 | Этикон Эндо-Серджери, Инк. | Surgical instrument with soft stop |
US9398911B2 (en) | 2013-03-01 | 2016-07-26 | Ethicon Endo-Surgery, Llc | Rotary powered surgical instruments with multiple degrees of freedom |
RU2672520C2 (en) | 2013-03-01 | 2018-11-15 | Этикон Эндо-Серджери, Инк. | Hingedly turnable surgical instruments with conducting ways for signal transfer |
US9345481B2 (en) | 2013-03-13 | 2016-05-24 | Ethicon Endo-Surgery, Llc | Staple cartridge tissue thickness sensor system |
US9629629B2 (en) | 2013-03-14 | 2017-04-25 | Ethicon Endo-Surgey, LLC | Control systems for surgical instruments |
US9883860B2 (en) | 2013-03-14 | 2018-02-06 | Ethicon Llc | Interchangeable shaft assemblies for use with a surgical instrument |
US9332984B2 (en) | 2013-03-27 | 2016-05-10 | Ethicon Endo-Surgery, Llc | Fastener cartridge assemblies |
US9572577B2 (en) | 2013-03-27 | 2017-02-21 | Ethicon Endo-Surgery, Llc | Fastener cartridge comprising a tissue thickness compensator including openings therein |
US9795384B2 (en) | 2013-03-27 | 2017-10-24 | Ethicon Llc | Fastener cartridge comprising a tissue thickness compensator and a gap setting element |
US9801626B2 (en) | 2013-04-16 | 2017-10-31 | Ethicon Llc | Modular motor driven surgical instruments with alignment features for aligning rotary drive shafts with surgical end effector shafts |
BR112015026109B1 (en) | 2013-04-16 | 2022-02-22 | Ethicon Endo-Surgery, Inc | surgical instrument |
WO2014172332A1 (en) * | 2013-04-18 | 2014-10-23 | 3M Innovative Properties Company | Nanosilica/clay compositions and coated articles, and methods of making the same |
US9574644B2 (en) | 2013-05-30 | 2017-02-21 | Ethicon Endo-Surgery, Llc | Power module for use with a surgical instrument |
US20150053746A1 (en) | 2013-08-23 | 2015-02-26 | Ethicon Endo-Surgery, Inc. | Torque optimization for surgical instruments |
JP6416260B2 (en) | 2013-08-23 | 2018-10-31 | エシコン エルエルシー | Firing member retractor for a powered surgical instrument |
US9180346B2 (en) | 2013-10-23 | 2015-11-10 | Acushnet Company | Golf balls having foam center containing clay particulate |
DE102013114586A1 (en) * | 2013-12-20 | 2015-06-25 | Teng-Lai Chen | Sterilization and deodorization structure of a personal care article |
US20150173756A1 (en) | 2013-12-23 | 2015-06-25 | Ethicon Endo-Surgery, Inc. | Surgical cutting and stapling methods |
US9724092B2 (en) | 2013-12-23 | 2017-08-08 | Ethicon Llc | Modular surgical instruments |
US9687232B2 (en) | 2013-12-23 | 2017-06-27 | Ethicon Llc | Surgical staples |
US9681870B2 (en) | 2013-12-23 | 2017-06-20 | Ethicon Llc | Articulatable surgical instruments with separate and distinct closing and firing systems |
US9839428B2 (en) | 2013-12-23 | 2017-12-12 | Ethicon Llc | Surgical cutting and stapling instruments with independent jaw control features |
US9642620B2 (en) | 2013-12-23 | 2017-05-09 | Ethicon Endo-Surgery, Llc | Surgical cutting and stapling instruments with articulatable end effectors |
US9962161B2 (en) | 2014-02-12 | 2018-05-08 | Ethicon Llc | Deliverable surgical instrument |
US11039621B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11039620B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US9622483B2 (en) | 2014-02-19 | 2017-04-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
JP6462004B2 (en) | 2014-02-24 | 2019-01-30 | エシコン エルエルシー | Fastening system with launcher lockout |
US9693777B2 (en) | 2014-02-24 | 2017-07-04 | Ethicon Llc | Implantable layers comprising a pressed region |
US20150272580A1 (en) | 2014-03-26 | 2015-10-01 | Ethicon Endo-Surgery, Inc. | Verification of number of battery exchanges/procedure count |
BR112016021943B1 (en) | 2014-03-26 | 2022-06-14 | Ethicon Endo-Surgery, Llc | SURGICAL INSTRUMENT FOR USE BY AN OPERATOR IN A SURGICAL PROCEDURE |
US9826977B2 (en) | 2014-03-26 | 2017-11-28 | Ethicon Llc | Sterilization verification circuit |
US9913642B2 (en) | 2014-03-26 | 2018-03-13 | Ethicon Llc | Surgical instrument comprising a sensor system |
US9820738B2 (en) | 2014-03-26 | 2017-11-21 | Ethicon Llc | Surgical instrument comprising interactive systems |
CA2944196A1 (en) * | 2014-04-09 | 2015-10-15 | Invista Technologies S.A R.L. | Water repellent, soil resistant, fluorine-free compositions |
US9801628B2 (en) | 2014-09-26 | 2017-10-31 | Ethicon Llc | Surgical staple and driver arrangements for staple cartridges |
CN106456176B (en) | 2014-04-16 | 2019-06-28 | 伊西康内外科有限责任公司 | Fastener cartridge including the extension with various configuration |
US20150297225A1 (en) | 2014-04-16 | 2015-10-22 | Ethicon Endo-Surgery, Inc. | Fastener cartridges including extensions having different configurations |
JP6532889B2 (en) | 2014-04-16 | 2019-06-19 | エシコン エルエルシーEthicon LLC | Fastener cartridge assembly and staple holder cover arrangement |
US9844369B2 (en) | 2014-04-16 | 2017-12-19 | Ethicon Llc | Surgical end effectors with firing element monitoring arrangements |
JP6612256B2 (en) | 2014-04-16 | 2019-11-27 | エシコン エルエルシー | Fastener cartridge with non-uniform fastener |
US20150342990A1 (en) * | 2014-05-29 | 2015-12-03 | Metabeauty, Inc | Methods and compositions for the use of silver to prevent and treat acne |
US10045781B2 (en) | 2014-06-13 | 2018-08-14 | Ethicon Llc | Closure lockout systems for surgical instruments |
JP5901703B2 (en) * | 2014-06-30 | 2016-04-13 | ユニ・チャーム株式会社 | Liquid material coating method and liquid material coating apparatus |
US10016199B2 (en) | 2014-09-05 | 2018-07-10 | Ethicon Llc | Polarity of hall magnet to identify cartridge type |
BR112017004361B1 (en) | 2014-09-05 | 2023-04-11 | Ethicon Llc | ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT |
US11311294B2 (en) | 2014-09-05 | 2022-04-26 | Cilag Gmbh International | Powered medical device including measurement of closure state of jaws |
US10105142B2 (en) | 2014-09-18 | 2018-10-23 | Ethicon Llc | Surgical stapler with plurality of cutting elements |
US11523821B2 (en) | 2014-09-26 | 2022-12-13 | Cilag Gmbh International | Method for creating a flexible staple line |
MX2017003960A (en) | 2014-09-26 | 2017-12-04 | Ethicon Llc | Surgical stapling buttresses and adjunct materials. |
US10076325B2 (en) | 2014-10-13 | 2018-09-18 | Ethicon Llc | Surgical stapling apparatus comprising a tissue stop |
US9924944B2 (en) | 2014-10-16 | 2018-03-27 | Ethicon Llc | Staple cartridge comprising an adjunct material |
US10517594B2 (en) | 2014-10-29 | 2019-12-31 | Ethicon Llc | Cartridge assemblies for surgical staplers |
US11141153B2 (en) | 2014-10-29 | 2021-10-12 | Cilag Gmbh International | Staple cartridges comprising driver arrangements |
US9844376B2 (en) | 2014-11-06 | 2017-12-19 | Ethicon Llc | Staple cartridge comprising a releasable adjunct material |
US10736636B2 (en) | 2014-12-10 | 2020-08-11 | Ethicon Llc | Articulatable surgical instrument system |
MX2017008108A (en) | 2014-12-18 | 2018-03-06 | Ethicon Llc | Surgical instrument with an anvil that is selectively movable about a discrete non-movable axis relative to a staple cartridge. |
US9987000B2 (en) | 2014-12-18 | 2018-06-05 | Ethicon Llc | Surgical instrument assembly comprising a flexible articulation system |
US10188385B2 (en) | 2014-12-18 | 2019-01-29 | Ethicon Llc | Surgical instrument system comprising lockable systems |
US10117649B2 (en) | 2014-12-18 | 2018-11-06 | Ethicon Llc | Surgical instrument assembly comprising a lockable articulation system |
US9943309B2 (en) | 2014-12-18 | 2018-04-17 | Ethicon Llc | Surgical instruments with articulatable end effectors and movable firing beam support arrangements |
US10085748B2 (en) | 2014-12-18 | 2018-10-02 | Ethicon Llc | Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors |
US9844374B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member |
US9844375B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Drive arrangements for articulatable surgical instruments |
US9993258B2 (en) | 2015-02-27 | 2018-06-12 | Ethicon Llc | Adaptable surgical instrument handle |
US11154301B2 (en) | 2015-02-27 | 2021-10-26 | Cilag Gmbh International | Modular stapling assembly |
US10180463B2 (en) | 2015-02-27 | 2019-01-15 | Ethicon Llc | Surgical apparatus configured to assess whether a performance parameter of the surgical apparatus is within an acceptable performance band |
US10045779B2 (en) | 2015-02-27 | 2018-08-14 | Ethicon Llc | Surgical instrument system comprising an inspection station |
US10617412B2 (en) | 2015-03-06 | 2020-04-14 | Ethicon Llc | System for detecting the mis-insertion of a staple cartridge into a surgical stapler |
US9924961B2 (en) | 2015-03-06 | 2018-03-27 | Ethicon Endo-Surgery, Llc | Interactive feedback system for powered surgical instruments |
US10045776B2 (en) | 2015-03-06 | 2018-08-14 | Ethicon Llc | Control techniques and sub-processor contained within modular shaft with select control processing from handle |
US9993248B2 (en) | 2015-03-06 | 2018-06-12 | Ethicon Endo-Surgery, Llc | Smart sensors with local signal processing |
US10245033B2 (en) | 2015-03-06 | 2019-04-02 | Ethicon Llc | Surgical instrument comprising a lockable battery housing |
US10687806B2 (en) | 2015-03-06 | 2020-06-23 | Ethicon Llc | Adaptive tissue compression techniques to adjust closure rates for multiple tissue types |
US10441279B2 (en) | 2015-03-06 | 2019-10-15 | Ethicon Llc | Multiple level thresholds to modify operation of powered surgical instruments |
US9808246B2 (en) | 2015-03-06 | 2017-11-07 | Ethicon Endo-Surgery, Llc | Method of operating a powered surgical instrument |
US9895148B2 (en) | 2015-03-06 | 2018-02-20 | Ethicon Endo-Surgery, Llc | Monitoring speed control and precision incrementing of motor for powered surgical instruments |
US9901342B2 (en) | 2015-03-06 | 2018-02-27 | Ethicon Endo-Surgery, Llc | Signal and power communication system positioned on a rotatable shaft |
US10548504B2 (en) | 2015-03-06 | 2020-02-04 | Ethicon Llc | Overlaid multi sensor radio frequency (RF) electrode system to measure tissue compression |
JP2020121162A (en) | 2015-03-06 | 2020-08-13 | エシコン エルエルシーEthicon LLC | Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement |
US10213201B2 (en) | 2015-03-31 | 2019-02-26 | Ethicon Llc | Stapling end effector configured to compensate for an uneven gap between a first jaw and a second jaw |
US10405594B2 (en) | 2015-05-21 | 2019-09-10 | International Textile Group, Inc. | Inner lining fabric |
US10335149B2 (en) | 2015-06-18 | 2019-07-02 | Ethicon Llc | Articulatable surgical instruments with composite firing beam structures with center firing support member for articulation support |
US10835249B2 (en) | 2015-08-17 | 2020-11-17 | Ethicon Llc | Implantable layers for a surgical instrument |
CN108348233B (en) | 2015-08-26 | 2021-05-07 | 伊西康有限责任公司 | Surgical staple strip for allowing changing staple characteristics and achieving easy cartridge loading |
US11103248B2 (en) | 2015-08-26 | 2021-08-31 | Cilag Gmbh International | Surgical staples for minimizing staple roll |
MX2022009705A (en) | 2015-08-26 | 2022-11-07 | Ethicon Llc | Surgical staples comprising hardness variations for improved fastening of tissue. |
US10357252B2 (en) | 2015-09-02 | 2019-07-23 | Ethicon Llc | Surgical staple configurations with camming surfaces located between portions supporting surgical staples |
MX2022006189A (en) | 2015-09-02 | 2022-06-16 | Ethicon Llc | Surgical staple configurations with camming surfaces located between portions supporting surgical staples. |
US10085751B2 (en) | 2015-09-23 | 2018-10-02 | Ethicon Llc | Surgical stapler having temperature-based motor control |
US10076326B2 (en) | 2015-09-23 | 2018-09-18 | Ethicon Llc | Surgical stapler having current mirror-based motor control |
US10363036B2 (en) | 2015-09-23 | 2019-07-30 | Ethicon Llc | Surgical stapler having force-based motor control |
US10327769B2 (en) | 2015-09-23 | 2019-06-25 | Ethicon Llc | Surgical stapler having motor control based on a drive system component |
US10105139B2 (en) | 2015-09-23 | 2018-10-23 | Ethicon Llc | Surgical stapler having downstream current-based motor control |
US10238386B2 (en) | 2015-09-23 | 2019-03-26 | Ethicon Llc | Surgical stapler having motor control based on an electrical parameter related to a motor current |
US10299878B2 (en) | 2015-09-25 | 2019-05-28 | Ethicon Llc | Implantable adjunct systems for determining adjunct skew |
US20170086829A1 (en) | 2015-09-30 | 2017-03-30 | Ethicon Endo-Surgery, Llc | Compressible adjunct with intermediate supporting structures |
US10478188B2 (en) | 2015-09-30 | 2019-11-19 | Ethicon Llc | Implantable layer comprising a constricted configuration |
US11890015B2 (en) | 2015-09-30 | 2024-02-06 | Cilag Gmbh International | Compressible adjunct with crossing spacer fibers |
US10980539B2 (en) | 2015-09-30 | 2021-04-20 | Ethicon Llc | Implantable adjunct comprising bonded layers |
US10327480B2 (en) * | 2015-12-21 | 2019-06-25 | Misbah Khan | Disposable liners for body areas |
US10292704B2 (en) | 2015-12-30 | 2019-05-21 | Ethicon Llc | Mechanisms for compensating for battery pack failure in powered surgical instruments |
US10265068B2 (en) | 2015-12-30 | 2019-04-23 | Ethicon Llc | Surgical instruments with separable motors and motor control circuits |
US10368865B2 (en) | 2015-12-30 | 2019-08-06 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
BR112018016098B1 (en) | 2016-02-09 | 2023-02-23 | Ethicon Llc | SURGICAL INSTRUMENT |
US10433837B2 (en) | 2016-02-09 | 2019-10-08 | Ethicon Llc | Surgical instruments with multiple link articulation arrangements |
US11213293B2 (en) | 2016-02-09 | 2022-01-04 | Cilag Gmbh International | Articulatable surgical instruments with single articulation link arrangements |
US11224426B2 (en) | 2016-02-12 | 2022-01-18 | Cilag Gmbh International | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10258331B2 (en) | 2016-02-12 | 2019-04-16 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10448948B2 (en) | 2016-02-12 | 2019-10-22 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10617413B2 (en) | 2016-04-01 | 2020-04-14 | Ethicon Llc | Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts |
US11284890B2 (en) | 2016-04-01 | 2022-03-29 | Cilag Gmbh International | Circular stapling system comprising an incisable tissue support |
US10456140B2 (en) | 2016-04-01 | 2019-10-29 | Ethicon Llc | Surgical stapling system comprising an unclamping lockout |
US10285705B2 (en) | 2016-04-01 | 2019-05-14 | Ethicon Llc | Surgical stapling system comprising a grooved forming pocket |
US10307159B2 (en) | 2016-04-01 | 2019-06-04 | Ethicon Llc | Surgical instrument handle assembly with reconfigurable grip portion |
US10335145B2 (en) | 2016-04-15 | 2019-07-02 | Ethicon Llc | Modular surgical instrument with configurable operating mode |
US10492783B2 (en) | 2016-04-15 | 2019-12-03 | Ethicon, Llc | Surgical instrument with improved stop/start control during a firing motion |
US10456137B2 (en) | 2016-04-15 | 2019-10-29 | Ethicon Llc | Staple formation detection mechanisms |
US10405859B2 (en) | 2016-04-15 | 2019-09-10 | Ethicon Llc | Surgical instrument with adjustable stop/start control during a firing motion |
US10357247B2 (en) | 2016-04-15 | 2019-07-23 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US10828028B2 (en) | 2016-04-15 | 2020-11-10 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US11607239B2 (en) | 2016-04-15 | 2023-03-21 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US11179150B2 (en) | 2016-04-15 | 2021-11-23 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US10426467B2 (en) | 2016-04-15 | 2019-10-01 | Ethicon Llc | Surgical instrument with detection sensors |
US11317917B2 (en) | 2016-04-18 | 2022-05-03 | Cilag Gmbh International | Surgical stapling system comprising a lockable firing assembly |
US10363037B2 (en) | 2016-04-18 | 2019-07-30 | Ethicon Llc | Surgical instrument system comprising a magnetic lockout |
US20170296173A1 (en) | 2016-04-18 | 2017-10-19 | Ethicon Endo-Surgery, Llc | Method for operating a surgical instrument |
USD826405S1 (en) | 2016-06-24 | 2018-08-21 | Ethicon Llc | Surgical fastener |
CN109310431B (en) | 2016-06-24 | 2022-03-04 | 伊西康有限责任公司 | Staple cartridge comprising wire staples and punch staples |
USD850617S1 (en) | 2016-06-24 | 2019-06-04 | Ethicon Llc | Surgical fastener cartridge |
US11000278B2 (en) | 2016-06-24 | 2021-05-11 | Ethicon Llc | Staple cartridge comprising wire staples and stamped staples |
USD847989S1 (en) | 2016-06-24 | 2019-05-07 | Ethicon Llc | Surgical fastener cartridge |
US10035969B2 (en) | 2016-07-22 | 2018-07-31 | United Technologies Corporation | Auxiliary emergency protective lubrication system for metal mechanical components |
US10695055B2 (en) | 2016-12-21 | 2020-06-30 | Ethicon Llc | Firing assembly comprising a lockout |
US10667810B2 (en) | 2016-12-21 | 2020-06-02 | Ethicon Llc | Closure members with cam surface arrangements for surgical instruments with separate and distinct closure and firing systems |
US20180168619A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Surgical stapling systems |
US11419606B2 (en) | 2016-12-21 | 2022-08-23 | Cilag Gmbh International | Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems |
JP7010956B2 (en) | 2016-12-21 | 2022-01-26 | エシコン エルエルシー | How to staple tissue |
US10675026B2 (en) | 2016-12-21 | 2020-06-09 | Ethicon Llc | Methods of stapling tissue |
US11191539B2 (en) | 2016-12-21 | 2021-12-07 | Cilag Gmbh International | Shaft assembly comprising a manually-operable retraction system for use with a motorized surgical instrument system |
CN110114014B (en) | 2016-12-21 | 2022-08-09 | 爱惜康有限责任公司 | Surgical instrument system including end effector and firing assembly lockout |
US20180168650A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Connection portions for disposable loading units for surgical stapling instruments |
US10888322B2 (en) | 2016-12-21 | 2021-01-12 | Ethicon Llc | Surgical instrument comprising a cutting member |
US20180168615A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument |
US11134942B2 (en) | 2016-12-21 | 2021-10-05 | Cilag Gmbh International | Surgical stapling instruments and staple-forming anvils |
US20180168625A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Surgical stapling instruments with smart staple cartridges |
US10426471B2 (en) | 2016-12-21 | 2019-10-01 | Ethicon Llc | Surgical instrument with multiple failure response modes |
US10568625B2 (en) | 2016-12-21 | 2020-02-25 | Ethicon Llc | Staple cartridges and arrangements of staples and staple cavities therein |
US10945727B2 (en) | 2016-12-21 | 2021-03-16 | Ethicon Llc | Staple cartridge with deformable driver retention features |
US10687810B2 (en) | 2016-12-21 | 2020-06-23 | Ethicon Llc | Stepped staple cartridge with tissue retention and gap setting features |
US11684367B2 (en) | 2016-12-21 | 2023-06-27 | Cilag Gmbh International | Stepped assembly having and end-of-life indicator |
US10993715B2 (en) | 2016-12-21 | 2021-05-04 | Ethicon Llc | Staple cartridge comprising staples with different clamping breadths |
US10835247B2 (en) | 2016-12-21 | 2020-11-17 | Ethicon Llc | Lockout arrangements for surgical end effectors |
JP6983893B2 (en) | 2016-12-21 | 2021-12-17 | エシコン エルエルシーEthicon LLC | Lockout configuration for surgical end effectors and replaceable tool assemblies |
MX2019007311A (en) | 2016-12-21 | 2019-11-18 | Ethicon Llc | Surgical stapling systems. |
US10624635B2 (en) | 2016-12-21 | 2020-04-21 | Ethicon Llc | Firing members with non-parallel jaw engagement features for surgical end effectors |
US10856868B2 (en) | 2016-12-21 | 2020-12-08 | Ethicon Llc | Firing member pin configurations |
US10499914B2 (en) | 2016-12-21 | 2019-12-10 | Ethicon Llc | Staple forming pocket arrangements |
JP2018102613A (en) * | 2016-12-27 | 2018-07-05 | 花王株式会社 | Absorbent article |
US10087320B2 (en) | 2017-02-17 | 2018-10-02 | Polydrop, Llc | Conductive polymer-matrix compositions and uses thereof |
JP7231227B2 (en) | 2017-02-22 | 2023-03-01 | コーネル ユニヴァーシティー | Mechanical vacuum dressing for mechanical management, protection and aspiration of small incisions |
JP7326162B2 (en) * | 2017-05-18 | 2023-08-15 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | Composite structure and method of forming same |
USD890784S1 (en) | 2017-06-20 | 2020-07-21 | Ethicon Llc | Display panel with changeable graphical user interface |
US10307170B2 (en) | 2017-06-20 | 2019-06-04 | Ethicon Llc | Method for closed loop control of motor velocity of a surgical stapling and cutting instrument |
US10779820B2 (en) | 2017-06-20 | 2020-09-22 | Ethicon Llc | Systems and methods for controlling motor speed according to user input for a surgical instrument |
US10881399B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument |
US10327767B2 (en) | 2017-06-20 | 2019-06-25 | Ethicon Llc | Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation |
US11382638B2 (en) | 2017-06-20 | 2022-07-12 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance |
US11517325B2 (en) | 2017-06-20 | 2022-12-06 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval |
US10980537B2 (en) | 2017-06-20 | 2021-04-20 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations |
US10624633B2 (en) | 2017-06-20 | 2020-04-21 | Ethicon Llc | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument |
US10368864B2 (en) | 2017-06-20 | 2019-08-06 | Ethicon Llc | Systems and methods for controlling displaying motor velocity for a surgical instrument |
US10888321B2 (en) | 2017-06-20 | 2021-01-12 | Ethicon Llc | Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument |
USD879808S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with graphical user interface |
US10813639B2 (en) | 2017-06-20 | 2020-10-27 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions |
US11653914B2 (en) | 2017-06-20 | 2023-05-23 | Cilag Gmbh International | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector |
US11071554B2 (en) | 2017-06-20 | 2021-07-27 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements |
USD879809S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with changeable graphical user interface |
US10646220B2 (en) | 2017-06-20 | 2020-05-12 | Ethicon Llc | Systems and methods for controlling displacement member velocity for a surgical instrument |
US10881396B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Surgical instrument with variable duration trigger arrangement |
US11090046B2 (en) | 2017-06-20 | 2021-08-17 | Cilag Gmbh International | Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument |
US10390841B2 (en) | 2017-06-20 | 2019-08-27 | Ethicon Llc | Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation |
US10772629B2 (en) | 2017-06-27 | 2020-09-15 | Ethicon Llc | Surgical anvil arrangements |
US10993716B2 (en) | 2017-06-27 | 2021-05-04 | Ethicon Llc | Surgical anvil arrangements |
US10856869B2 (en) | 2017-06-27 | 2020-12-08 | Ethicon Llc | Surgical anvil arrangements |
US11324503B2 (en) | 2017-06-27 | 2022-05-10 | Cilag Gmbh International | Surgical firing member arrangements |
US11266405B2 (en) | 2017-06-27 | 2022-03-08 | Cilag Gmbh International | Surgical anvil manufacturing methods |
US10631859B2 (en) | 2017-06-27 | 2020-04-28 | Ethicon Llc | Articulation systems for surgical instruments |
USD906355S1 (en) | 2017-06-28 | 2020-12-29 | Ethicon Llc | Display screen or portion thereof with a graphical user interface for a surgical instrument |
US10903685B2 (en) | 2017-06-28 | 2021-01-26 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies forming capacitive channels |
EP3420947B1 (en) | 2017-06-28 | 2022-05-25 | Cilag GmbH International | Surgical instrument comprising selectively actuatable rotatable couplers |
US10639037B2 (en) | 2017-06-28 | 2020-05-05 | Ethicon Llc | Surgical instrument with axially movable closure member |
US11259805B2 (en) | 2017-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical instrument comprising firing member supports |
US11246592B2 (en) | 2017-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical instrument comprising an articulation system lockable to a frame |
US10211586B2 (en) | 2017-06-28 | 2019-02-19 | Ethicon Llc | Surgical shaft assemblies with watertight housings |
US10716614B2 (en) | 2017-06-28 | 2020-07-21 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies with increased contact pressure |
US11058424B2 (en) | 2017-06-28 | 2021-07-13 | Cilag Gmbh International | Surgical instrument comprising an offset articulation joint |
USD869655S1 (en) | 2017-06-28 | 2019-12-10 | Ethicon Llc | Surgical fastener cartridge |
US11564686B2 (en) | 2017-06-28 | 2023-01-31 | Cilag Gmbh International | Surgical shaft assemblies with flexible interfaces |
USD854151S1 (en) | 2017-06-28 | 2019-07-16 | Ethicon Llc | Surgical instrument shaft |
USD851762S1 (en) | 2017-06-28 | 2019-06-18 | Ethicon Llc | Anvil |
US10765427B2 (en) | 2017-06-28 | 2020-09-08 | Ethicon Llc | Method for articulating a surgical instrument |
US11007022B2 (en) | 2017-06-29 | 2021-05-18 | Ethicon Llc | Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument |
US10258418B2 (en) | 2017-06-29 | 2019-04-16 | Ethicon Llc | System for controlling articulation forces |
US10898183B2 (en) | 2017-06-29 | 2021-01-26 | Ethicon Llc | Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing |
US10398434B2 (en) | 2017-06-29 | 2019-09-03 | Ethicon Llc | Closed loop velocity control of closure member for robotic surgical instrument |
US10932772B2 (en) | 2017-06-29 | 2021-03-02 | Ethicon Llc | Methods for closed loop velocity control for robotic surgical instrument |
US11304695B2 (en) | 2017-08-03 | 2022-04-19 | Cilag Gmbh International | Surgical system shaft interconnection |
US11471155B2 (en) | 2017-08-03 | 2022-10-18 | Cilag Gmbh International | Surgical system bailout |
US11944300B2 (en) | 2017-08-03 | 2024-04-02 | Cilag Gmbh International | Method for operating a surgical system bailout |
US11974742B2 (en) | 2017-08-03 | 2024-05-07 | Cilag Gmbh International | Surgical system comprising an articulation bailout |
US11399829B2 (en) | 2017-09-29 | 2022-08-02 | Cilag Gmbh International | Systems and methods of initiating a power shutdown mode for a surgical instrument |
US10729501B2 (en) | 2017-09-29 | 2020-08-04 | Ethicon Llc | Systems and methods for language selection of a surgical instrument |
US10743872B2 (en) | 2017-09-29 | 2020-08-18 | Ethicon Llc | System and methods for controlling a display of a surgical instrument |
USD907648S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
US10765429B2 (en) | 2017-09-29 | 2020-09-08 | Ethicon Llc | Systems and methods for providing alerts according to the operational state of a surgical instrument |
USD917500S1 (en) | 2017-09-29 | 2021-04-27 | Ethicon Llc | Display screen or portion thereof with graphical user interface |
US10796471B2 (en) | 2017-09-29 | 2020-10-06 | Ethicon Llc | Systems and methods of displaying a knife position for a surgical instrument |
USD907647S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
US11090075B2 (en) | 2017-10-30 | 2021-08-17 | Cilag Gmbh International | Articulation features for surgical end effector |
US11134944B2 (en) | 2017-10-30 | 2021-10-05 | Cilag Gmbh International | Surgical stapler knife motion controls |
US10842490B2 (en) | 2017-10-31 | 2020-11-24 | Ethicon Llc | Cartridge body design with force reduction based on firing completion |
US10779903B2 (en) | 2017-10-31 | 2020-09-22 | Ethicon Llc | Positive shaft rotation lock activated by jaw closure |
AU2018378653B2 (en) | 2017-12-06 | 2024-09-05 | Cornell University | Manually-operated negative pressure wound therapy (NPWT) bandage with improved pump efficiency, automatic pressure indicator and automatic pressure limiter |
US11071543B2 (en) | 2017-12-15 | 2021-07-27 | Cilag Gmbh International | Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges |
US10869666B2 (en) | 2017-12-15 | 2020-12-22 | Ethicon Llc | Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument |
US11006955B2 (en) | 2017-12-15 | 2021-05-18 | Ethicon Llc | End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments |
US10743874B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Sealed adapters for use with electromechanical surgical instruments |
US10828033B2 (en) | 2017-12-15 | 2020-11-10 | Ethicon Llc | Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto |
US11197670B2 (en) | 2017-12-15 | 2021-12-14 | Cilag Gmbh International | Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed |
US10779825B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments |
US10779826B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Methods of operating surgical end effectors |
US10966718B2 (en) | 2017-12-15 | 2021-04-06 | Ethicon Llc | Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments |
US10743875B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member |
US11033267B2 (en) | 2017-12-15 | 2021-06-15 | Ethicon Llc | Systems and methods of controlling a clamping member firing rate of a surgical instrument |
US10687813B2 (en) | 2017-12-15 | 2020-06-23 | Ethicon Llc | Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments |
US11045270B2 (en) | 2017-12-19 | 2021-06-29 | Cilag Gmbh International | Robotic attachment comprising exterior drive actuator |
US11020112B2 (en) | 2017-12-19 | 2021-06-01 | Ethicon Llc | Surgical tools configured for interchangeable use with different controller interfaces |
US10729509B2 (en) | 2017-12-19 | 2020-08-04 | Ethicon Llc | Surgical instrument comprising closure and firing locking mechanism |
US10835330B2 (en) | 2017-12-19 | 2020-11-17 | Ethicon Llc | Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly |
US10716565B2 (en) | 2017-12-19 | 2020-07-21 | Ethicon Llc | Surgical instruments with dual articulation drivers |
USD910847S1 (en) | 2017-12-19 | 2021-02-16 | Ethicon Llc | Surgical instrument assembly |
US11129680B2 (en) | 2017-12-21 | 2021-09-28 | Cilag Gmbh International | Surgical instrument comprising a projector |
US10743868B2 (en) | 2017-12-21 | 2020-08-18 | Ethicon Llc | Surgical instrument comprising a pivotable distal head |
US11076853B2 (en) | 2017-12-21 | 2021-08-03 | Cilag Gmbh International | Systems and methods of displaying a knife position during transection for a surgical instrument |
US11311290B2 (en) | 2017-12-21 | 2022-04-26 | Cilag Gmbh International | Surgical instrument comprising an end effector dampener |
EP3502056A1 (en) * | 2017-12-22 | 2019-06-26 | Imertech Sas | Co-synthesis of phyllominerals with metallic particles and products obtained therefrom |
CN108066068A (en) * | 2017-12-29 | 2018-05-25 | 广东川田卫生用品有限公司 | A kind of sanitary napkin |
WO2019155097A1 (en) * | 2018-02-09 | 2019-08-15 | Montesa Productos Cerámicos, S.A. | Method for obtaining clay nanoparticles and product made from said clay nanoparticles |
US11083458B2 (en) | 2018-08-20 | 2021-08-10 | Cilag Gmbh International | Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions |
US10842492B2 (en) | 2018-08-20 | 2020-11-24 | Ethicon Llc | Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system |
US11291440B2 (en) | 2018-08-20 | 2022-04-05 | Cilag Gmbh International | Method for operating a powered articulatable surgical instrument |
US10779821B2 (en) | 2018-08-20 | 2020-09-22 | Ethicon Llc | Surgical stapler anvils with tissue stop features configured to avoid tissue pinch |
US10856870B2 (en) | 2018-08-20 | 2020-12-08 | Ethicon Llc | Switching arrangements for motor powered articulatable surgical instruments |
USD914878S1 (en) | 2018-08-20 | 2021-03-30 | Ethicon Llc | Surgical instrument anvil |
US10912559B2 (en) | 2018-08-20 | 2021-02-09 | Ethicon Llc | Reinforced deformable anvil tip for surgical stapler anvil |
US11039834B2 (en) | 2018-08-20 | 2021-06-22 | Cilag Gmbh International | Surgical stapler anvils with staple directing protrusions and tissue stability features |
US11207065B2 (en) | 2018-08-20 | 2021-12-28 | Cilag Gmbh International | Method for fabricating surgical stapler anvils |
US11045192B2 (en) | 2018-08-20 | 2021-06-29 | Cilag Gmbh International | Fabricating techniques for surgical stapler anvils |
US11253256B2 (en) | 2018-08-20 | 2022-02-22 | Cilag Gmbh International | Articulatable motor powered surgical instruments with dedicated articulation motor arrangements |
US11324501B2 (en) | 2018-08-20 | 2022-05-10 | Cilag Gmbh International | Surgical stapling devices with improved closure members |
CN109200339B (en) * | 2018-09-12 | 2021-03-05 | 华东理工大学 | Composite material, raw material composition, bone restoration body, preparation method and application |
US11147551B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11172929B2 (en) | 2019-03-25 | 2021-11-16 | Cilag Gmbh International | Articulation drive arrangements for surgical systems |
US11147553B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11696761B2 (en) | 2019-03-25 | 2023-07-11 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11432816B2 (en) | 2019-04-30 | 2022-09-06 | Cilag Gmbh International | Articulation pin for a surgical instrument |
US11426251B2 (en) | 2019-04-30 | 2022-08-30 | Cilag Gmbh International | Articulation directional lights on a surgical instrument |
US11648009B2 (en) | 2019-04-30 | 2023-05-16 | Cilag Gmbh International | Rotatable jaw tip for a surgical instrument |
US11452528B2 (en) | 2019-04-30 | 2022-09-27 | Cilag Gmbh International | Articulation actuators for a surgical instrument |
US11471157B2 (en) | 2019-04-30 | 2022-10-18 | Cilag Gmbh International | Articulation control mapping for a surgical instrument |
US11253254B2 (en) | 2019-04-30 | 2022-02-22 | Cilag Gmbh International | Shaft rotation actuator on a surgical instrument |
US11903581B2 (en) | 2019-04-30 | 2024-02-20 | Cilag Gmbh International | Methods for stapling tissue using a surgical instrument |
US11684434B2 (en) | 2019-06-28 | 2023-06-27 | Cilag Gmbh International | Surgical RFID assemblies for instrument operational setting control |
US11376098B2 (en) | 2019-06-28 | 2022-07-05 | Cilag Gmbh International | Surgical instrument system comprising an RFID system |
US11627959B2 (en) | 2019-06-28 | 2023-04-18 | Cilag Gmbh International | Surgical instruments including manual and powered system lockouts |
US11246678B2 (en) | 2019-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical stapling system having a frangible RFID tag |
US11399837B2 (en) | 2019-06-28 | 2022-08-02 | Cilag Gmbh International | Mechanisms for motor control adjustments of a motorized surgical instrument |
US11229437B2 (en) | 2019-06-28 | 2022-01-25 | Cilag Gmbh International | Method for authenticating the compatibility of a staple cartridge with a surgical instrument |
US11497492B2 (en) | 2019-06-28 | 2022-11-15 | Cilag Gmbh International | Surgical instrument including an articulation lock |
US11660163B2 (en) | 2019-06-28 | 2023-05-30 | Cilag Gmbh International | Surgical system with RFID tags for updating motor assembly parameters |
US11291451B2 (en) | 2019-06-28 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with battery compatibility verification functionality |
US11298127B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Interational | Surgical stapling system having a lockout mechanism for an incompatible cartridge |
US11224497B2 (en) | 2019-06-28 | 2022-01-18 | Cilag Gmbh International | Surgical systems with multiple RFID tags |
US11478241B2 (en) | 2019-06-28 | 2022-10-25 | Cilag Gmbh International | Staple cartridge including projections |
US11259803B2 (en) | 2019-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical stapling system having an information encryption protocol |
US11219455B2 (en) | 2019-06-28 | 2022-01-11 | Cilag Gmbh International | Surgical instrument including a lockout key |
US11426167B2 (en) | 2019-06-28 | 2022-08-30 | Cilag Gmbh International | Mechanisms for proper anvil attachment surgical stapling head assembly |
US11553971B2 (en) | 2019-06-28 | 2023-01-17 | Cilag Gmbh International | Surgical RFID assemblies for display and communication |
US12004740B2 (en) | 2019-06-28 | 2024-06-11 | Cilag Gmbh International | Surgical stapling system having an information decryption protocol |
US11298132B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Inlernational | Staple cartridge including a honeycomb extension |
US11523822B2 (en) | 2019-06-28 | 2022-12-13 | Cilag Gmbh International | Battery pack including a circuit interrupter |
US11638587B2 (en) | 2019-06-28 | 2023-05-02 | Cilag Gmbh International | RFID identification systems for surgical instruments |
US11464601B2 (en) | 2019-06-28 | 2022-10-11 | Cilag Gmbh International | Surgical instrument comprising an RFID system for tracking a movable component |
US11771419B2 (en) | 2019-06-28 | 2023-10-03 | Cilag Gmbh International | Packaging for a replaceable component of a surgical stapling system |
US11051807B2 (en) | 2019-06-28 | 2021-07-06 | Cilag Gmbh International | Packaging assembly including a particulate trap |
US11911032B2 (en) | 2019-12-19 | 2024-02-27 | Cilag Gmbh International | Staple cartridge comprising a seating cam |
US12035913B2 (en) | 2019-12-19 | 2024-07-16 | Cilag Gmbh International | Staple cartridge comprising a deployable knife |
US11931033B2 (en) | 2019-12-19 | 2024-03-19 | Cilag Gmbh International | Staple cartridge comprising a latch lockout |
US11607219B2 (en) | 2019-12-19 | 2023-03-21 | Cilag Gmbh International | Staple cartridge comprising a detachable tissue cutting knife |
US11234698B2 (en) | 2019-12-19 | 2022-02-01 | Cilag Gmbh International | Stapling system comprising a clamp lockout and a firing lockout |
US11291447B2 (en) | 2019-12-19 | 2022-04-05 | Cilag Gmbh International | Stapling instrument comprising independent jaw closing and staple firing systems |
US11304696B2 (en) | 2019-12-19 | 2022-04-19 | Cilag Gmbh International | Surgical instrument comprising a powered articulation system |
US11701111B2 (en) | 2019-12-19 | 2023-07-18 | Cilag Gmbh International | Method for operating a surgical stapling instrument |
US11576672B2 (en) | 2019-12-19 | 2023-02-14 | Cilag Gmbh International | Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw |
US11844520B2 (en) | 2019-12-19 | 2023-12-19 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11529137B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11504122B2 (en) | 2019-12-19 | 2022-11-22 | Cilag Gmbh International | Surgical instrument comprising a nested firing member |
US11446029B2 (en) | 2019-12-19 | 2022-09-20 | Cilag Gmbh International | Staple cartridge comprising projections extending from a curved deck surface |
US11529139B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Motor driven surgical instrument |
US11464512B2 (en) | 2019-12-19 | 2022-10-11 | Cilag Gmbh International | Staple cartridge comprising a curved deck surface |
US11559304B2 (en) | 2019-12-19 | 2023-01-24 | Cilag Gmbh International | Surgical instrument comprising a rapid closure mechanism |
USD975851S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD975278S1 (en) | 2020-06-02 | 2023-01-10 | Cilag Gmbh International | Staple cartridge |
USD974560S1 (en) | 2020-06-02 | 2023-01-03 | Cilag Gmbh International | Staple cartridge |
USD975850S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD966512S1 (en) | 2020-06-02 | 2022-10-11 | Cilag Gmbh International | Staple cartridge |
USD967421S1 (en) | 2020-06-02 | 2022-10-18 | Cilag Gmbh International | Staple cartridge |
USD976401S1 (en) | 2020-06-02 | 2023-01-24 | Cilag Gmbh International | Staple cartridge |
US20220031350A1 (en) | 2020-07-28 | 2022-02-03 | Cilag Gmbh International | Surgical instruments with double pivot articulation joint arrangements |
CN112006032B (en) * | 2020-08-31 | 2021-06-11 | 中国科学院地球环境研究所 | Preparation method of intercalation type metal oxide antibacterial agent |
US11717289B2 (en) | 2020-10-29 | 2023-08-08 | Cilag Gmbh International | Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable |
US11452526B2 (en) | 2020-10-29 | 2022-09-27 | Cilag Gmbh International | Surgical instrument comprising a staged voltage regulation start-up system |
US11931025B2 (en) | 2020-10-29 | 2024-03-19 | Cilag Gmbh International | Surgical instrument comprising a releasable closure drive lock |
US11896217B2 (en) | 2020-10-29 | 2024-02-13 | Cilag Gmbh International | Surgical instrument comprising an articulation lock |
US11617577B2 (en) | 2020-10-29 | 2023-04-04 | Cilag Gmbh International | Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable |
USD980425S1 (en) | 2020-10-29 | 2023-03-07 | Cilag Gmbh International | Surgical instrument assembly |
US11779330B2 (en) | 2020-10-29 | 2023-10-10 | Cilag Gmbh International | Surgical instrument comprising a jaw alignment system |
US11517390B2 (en) | 2020-10-29 | 2022-12-06 | Cilag Gmbh International | Surgical instrument comprising a limited travel switch |
US12053175B2 (en) | 2020-10-29 | 2024-08-06 | Cilag Gmbh International | Surgical instrument comprising a stowed closure actuator stop |
USD1013170S1 (en) | 2020-10-29 | 2024-01-30 | Cilag Gmbh International | Surgical instrument assembly |
US11844518B2 (en) | 2020-10-29 | 2023-12-19 | Cilag Gmbh International | Method for operating a surgical instrument |
US11534259B2 (en) | 2020-10-29 | 2022-12-27 | Cilag Gmbh International | Surgical instrument comprising an articulation indicator |
US11744581B2 (en) | 2020-12-02 | 2023-09-05 | Cilag Gmbh International | Powered surgical instruments with multi-phase tissue treatment |
US11944296B2 (en) | 2020-12-02 | 2024-04-02 | Cilag Gmbh International | Powered surgical instruments with external connectors |
US11849943B2 (en) | 2020-12-02 | 2023-12-26 | Cilag Gmbh International | Surgical instrument with cartridge release mechanisms |
US11653915B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Surgical instruments with sled location detection and adjustment features |
US11678882B2 (en) | 2020-12-02 | 2023-06-20 | Cilag Gmbh International | Surgical instruments with interactive features to remedy incidental sled movements |
US11627960B2 (en) | 2020-12-02 | 2023-04-18 | Cilag Gmbh International | Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections |
US11737751B2 (en) | 2020-12-02 | 2023-08-29 | Cilag Gmbh International | Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings |
US11653920B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Powered surgical instruments with communication interfaces through sterile barrier |
US11890010B2 (en) | 2020-12-02 | 2024-02-06 | Cllag GmbH International | Dual-sided reinforced reload for surgical instruments |
US11751869B2 (en) | 2021-02-26 | 2023-09-12 | Cilag Gmbh International | Monitoring of multiple sensors over time to detect moving characteristics of tissue |
US11925349B2 (en) | 2021-02-26 | 2024-03-12 | Cilag Gmbh International | Adjustment to transfer parameters to improve available power |
US11696757B2 (en) | 2021-02-26 | 2023-07-11 | Cilag Gmbh International | Monitoring of internal systems to detect and track cartridge motion status |
US12108951B2 (en) | 2021-02-26 | 2024-10-08 | Cilag Gmbh International | Staple cartridge comprising a sensing array and a temperature control system |
US11950777B2 (en) | 2021-02-26 | 2024-04-09 | Cilag Gmbh International | Staple cartridge comprising an information access control system |
US11980362B2 (en) | 2021-02-26 | 2024-05-14 | Cilag Gmbh International | Surgical instrument system comprising a power transfer coil |
US11701113B2 (en) | 2021-02-26 | 2023-07-18 | Cilag Gmbh International | Stapling instrument comprising a separate power antenna and a data transfer antenna |
US11744583B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Distal communication array to tune frequency of RF systems |
US11723657B2 (en) | 2021-02-26 | 2023-08-15 | Cilag Gmbh International | Adjustable communication based on available bandwidth and power capacity |
US11812964B2 (en) | 2021-02-26 | 2023-11-14 | Cilag Gmbh International | Staple cartridge comprising a power management circuit |
US11730473B2 (en) | 2021-02-26 | 2023-08-22 | Cilag Gmbh International | Monitoring of manufacturing life-cycle |
US11950779B2 (en) | 2021-02-26 | 2024-04-09 | Cilag Gmbh International | Method of powering and communicating with a staple cartridge |
US11793514B2 (en) | 2021-02-26 | 2023-10-24 | Cilag Gmbh International | Staple cartridge comprising sensor array which may be embedded in cartridge body |
US11749877B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Stapling instrument comprising a signal antenna |
US11826012B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising a pulsed motor-driven firing rack |
US11806011B2 (en) | 2021-03-22 | 2023-11-07 | Cilag Gmbh International | Stapling instrument comprising tissue compression systems |
US11826042B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Surgical instrument comprising a firing drive including a selectable leverage mechanism |
US11737749B2 (en) | 2021-03-22 | 2023-08-29 | Cilag Gmbh International | Surgical stapling instrument comprising a retraction system |
US11723658B2 (en) | 2021-03-22 | 2023-08-15 | Cilag Gmbh International | Staple cartridge comprising a firing lockout |
US11717291B2 (en) | 2021-03-22 | 2023-08-08 | Cilag Gmbh International | Staple cartridge comprising staples configured to apply different tissue compression |
US11759202B2 (en) | 2021-03-22 | 2023-09-19 | Cilag Gmbh International | Staple cartridge comprising an implantable layer |
US11896219B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Mating features between drivers and underside of a cartridge deck |
US11857183B2 (en) | 2021-03-24 | 2024-01-02 | Cilag Gmbh International | Stapling assembly components having metal substrates and plastic bodies |
US11786243B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Firing members having flexible portions for adapting to a load during a surgical firing stroke |
US11786239B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Surgical instrument articulation joint arrangements comprising multiple moving linkage features |
US12102323B2 (en) | 2021-03-24 | 2024-10-01 | Cilag Gmbh International | Rotary-driven surgical stapling assembly comprising a floatable component |
US11793516B2 (en) | 2021-03-24 | 2023-10-24 | Cilag Gmbh International | Surgical staple cartridge comprising longitudinal support beam |
US11944336B2 (en) | 2021-03-24 | 2024-04-02 | Cilag Gmbh International | Joint arrangements for multi-planar alignment and support of operational drive shafts in articulatable surgical instruments |
US11849944B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Drivers for fastener cartridge assemblies having rotary drive screws |
US11832816B2 (en) | 2021-03-24 | 2023-12-05 | Cilag Gmbh International | Surgical stapling assembly comprising nonplanar staples and planar staples |
US11896218B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Method of using a powered stapling device |
US11903582B2 (en) | 2021-03-24 | 2024-02-20 | Cilag Gmbh International | Leveraging surfaces for cartridge installation |
US11744603B2 (en) | 2021-03-24 | 2023-09-05 | Cilag Gmbh International | Multi-axis pivot joints for surgical instruments and methods for manufacturing same |
US11849945B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Rotary-driven surgical stapling assembly comprising eccentrically driven firing member |
US11826047B2 (en) | 2021-05-28 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising jaw mounts |
WO2023044022A1 (en) * | 2021-09-16 | 2023-03-23 | Cupron Inc. | Fibers with embedded particles and methods of producing fibers with embedded particles |
US11957337B2 (en) | 2021-10-18 | 2024-04-16 | Cilag Gmbh International | Surgical stapling assembly with offset ramped drive surfaces |
US11980363B2 (en) | 2021-10-18 | 2024-05-14 | Cilag Gmbh International | Row-to-row staple array variations |
US11877745B2 (en) | 2021-10-18 | 2024-01-23 | Cilag Gmbh International | Surgical stapling assembly having longitudinally-repeating staple leg clusters |
US11937816B2 (en) | 2021-10-28 | 2024-03-26 | Cilag Gmbh International | Electrical lead arrangements for surgical instruments |
US12089841B2 (en) | 2021-10-28 | 2024-09-17 | Cilag CmbH International | Staple cartridge identification systems |
CN114405486B (en) * | 2021-11-17 | 2023-06-23 | 重庆科技学院 | Preparation method of porous cryogel with antifouling and antibacterial functions and dye adsorption preventing functions |
CN115521422B (en) * | 2022-10-24 | 2023-10-24 | 上海大学 | Method for preparing polyacrylate Pickering composite emulsion by edge modification of lithium magnesium silicate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050013759A1 (en) * | 1996-08-14 | 2005-01-20 | Grow Ann E. | Practical method for preparing inorganic nanophase materials |
US8088485B2 (en) * | 2002-11-26 | 2012-01-03 | Honda Motor Co., Ltd. | Method for synthesis of metal nanoparticles |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US449978A (en) * | 1891-04-07 | Oliver sweeney | ||
US598169A (en) * | 1898-02-01 | Hook and eye | ||
US3440181A (en) * | 1965-03-22 | 1969-04-22 | Dow Chemical Co | Metal coated vermicular expanded graphite and polymer composition containing same |
US4449978A (en) * | 1981-08-31 | 1984-05-22 | Air Products And Chemicals, Inc. | Nonwoven products having low residual free formaldehyde content |
US4687478A (en) * | 1984-03-20 | 1987-08-18 | The Procter & Gamble Company | Shaped sanitary napkin with flaps |
US4589876A (en) * | 1983-07-05 | 1986-05-20 | The Procter & Gamble Company | Sanitary napkin |
US4640810A (en) * | 1984-06-12 | 1987-02-03 | Scan Web Of North America, Inc. | System for producing an air laid web |
US4608047A (en) * | 1985-05-28 | 1986-08-26 | Personal Products Company | Sanitary napkin attachment means |
US4739007A (en) * | 1985-09-30 | 1988-04-19 | Kabushiki Kaisha Toyota Chou Kenkyusho | Composite material and process for manufacturing same |
US4900320C1 (en) * | 1986-06-16 | 2001-07-03 | Mcneil Ppc Inc | Sanitary napkin with panty gathering flaps |
US5143954A (en) * | 1990-11-27 | 1992-09-01 | Rohm And Haas Company | Low-formaldehyde, self-crosslinking polymer latex composition |
US5415926A (en) * | 1993-02-25 | 1995-05-16 | National Starch And Chemical Investment Holding Corporation | Process for reducing the free aldehyde content in N-alkylol amide monomers |
JPH07173022A (en) * | 1993-12-17 | 1995-07-11 | Asahi Chem Ind Co Ltd | Antimicrobial agent |
ES2202370T3 (en) * | 1994-09-06 | 2004-04-01 | Scan-Web I/S | PROCEDURE AND SYSTEM FOR MANUFACTURING THROUGH AIR WRAPPED BANDS OF PAPER CONTAINING AN ABSORBENT POWDER. |
ES2144649T3 (en) * | 1994-11-18 | 2000-06-16 | Procter & Gamble | DETERGENT COMPOSITIONS CONTAINING LIPASE AND PROTEASE. |
US5576282A (en) * | 1995-09-11 | 1996-11-19 | The Procter & Gamble Company | Color-safe bleach boosters, compositions and laundry methods employing same |
US5869033A (en) * | 1996-04-12 | 1999-02-09 | Enviroderm Pharmaceuticals,Inc. | Method of preventing skin irritation caused by fecal enzymes |
JPH10182142A (en) | 1996-10-23 | 1998-07-07 | Osaki Kogyo Kk | Metallic fine particle/solid carrier composition, its use and production |
US5866242A (en) * | 1997-01-17 | 1999-02-02 | Rayonier Inc. | Soft, strong, absorbent material for use in absorbent articles |
US5985169A (en) * | 1997-05-23 | 1999-11-16 | W.R. Grace & Co.-Conn. | Oxygen scavenging metal-loaded high surface area particulate compositions |
JP2002531640A (en) * | 1998-12-07 | 2002-09-24 | イーストマン ケミカル カンパニー | Polymer / clay nanocomposites with improved gas barrier properties, including clay materials having a mixture of two or more organic cations, and methods of making the same |
EP1066825A1 (en) | 1999-06-17 | 2001-01-10 | The Procter & Gamble Company | An anti-microbial body care product |
US6492453B1 (en) * | 1999-09-24 | 2002-12-10 | Alphagary Corporation | Low smoke emission, low corrosivity, low toxicity, low heat release, flame retardant, zero halogen polymeric compositions |
BR0113998A (en) * | 2000-09-21 | 2003-08-12 | Rohm & Haas | Process for preparing an aqueous nanocomposite dispersion |
CN1317328C (en) * | 2000-09-21 | 2007-05-23 | 罗姆和哈斯公司 | Aqueous nanocomposite dispersions: processes, compositions, and uses thereof |
US6518324B1 (en) * | 2000-11-28 | 2003-02-11 | Atofina Chemicals, Inc. | Polymer foam containing nanoclay |
US6497690B2 (en) * | 2000-12-19 | 2002-12-24 | Mcneil-Ppc, Inc. | Descrete absorbent articles |
AR032424A1 (en) * | 2001-01-30 | 2003-11-05 | Procter & Gamble | COATING COMPOSITIONS TO MODIFY SURFACES. |
FR2825270B1 (en) * | 2001-05-31 | 2003-08-08 | Oreal | COMPOSITION OF AEROSOL CONTAINING SILICATE PARTICLES AND SURFACTANTS |
WO2003002089A1 (en) * | 2001-06-29 | 2003-01-09 | Dow Global Technologies Inc. | Superabsorbent carboxyl-containing polymers with odor control properties and method for preparation |
KR20100028674A (en) * | 2001-06-29 | 2010-03-12 | 가부시키가이샤 시세이도 | Composite powders and skin preparations for external use containing the same |
AU2001270347B2 (en) * | 2001-07-06 | 2006-08-10 | The University Of Queensland | Metal oxide nanoparticles in an exfoliated silicate framework |
CN2512413Y (en) * | 2001-11-01 | 2002-09-25 | 上海兰格科技有限公司 | Antiseptic high absorption composite material |
US7753896B2 (en) * | 2001-12-19 | 2010-07-13 | Mcneil-Ppc, Inc. | Drapeable absorbent article |
US6743463B2 (en) * | 2002-03-28 | 2004-06-01 | Scimed Life Systems, Inc. | Method for spray-coating a medical device having a tubular wall such as a stent |
US7578997B2 (en) * | 2002-04-30 | 2009-08-25 | Kimberly-Clark Worldwide, Inc. | Metal ion modified high surface area materials for odor removal and control |
US7005408B2 (en) * | 2002-05-01 | 2006-02-28 | Mcneil-Ppc, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
US7776425B2 (en) | 2003-01-21 | 2010-08-17 | The Penn State Research Foundation | Nanoparticle coated nanostructured surfaces for detection, catalysis and device applications |
US7744709B2 (en) * | 2005-08-22 | 2010-06-29 | United Technologies Corporation | Welding repair method for full hoop structures |
-
2004
- 2004-11-01 DE DE602004015134T patent/DE602004015134D1/en active Active
- 2004-11-01 AT AT04817506T patent/ATE405300T1/en not_active IP Right Cessation
- 2004-11-01 CN CN2004800359771A patent/CN1925879B/en not_active Expired - Fee Related
- 2004-11-01 US US10/979,365 patent/US20050175649A1/en not_active Abandoned
- 2004-11-01 US US10/979,364 patent/US7988779B2/en not_active Expired - Fee Related
- 2004-11-01 JP JP2006538421A patent/JP2007519615A/en active Pending
- 2004-11-01 BR BRPI0416114-9A patent/BRPI0416114A/en not_active IP Right Cessation
- 2004-11-01 EP EP04800553A patent/EP1682193B1/en not_active Not-in-force
- 2004-11-01 WO PCT/US2004/036373 patent/WO2005042041A1/en active Application Filing
- 2004-11-01 AU AU2004285578A patent/AU2004285578B2/en not_active Ceased
- 2004-11-01 EP EP04817506A patent/EP1677843B1/en not_active Not-in-force
- 2004-11-01 CN CN200480035982A patent/CN100594944C/en not_active Expired - Fee Related
- 2004-11-01 CA CA2544119A patent/CA2544119C/en not_active Expired - Fee Related
- 2004-11-01 CA CA2544109A patent/CA2544109C/en not_active Expired - Fee Related
- 2004-11-01 ES ES04817506T patent/ES2311879T3/en active Active
- 2004-11-01 BR BRPI0415633-1A patent/BRPI0415633B1/en not_active IP Right Cessation
- 2004-11-01 AT AT04800553T patent/ATE401100T1/en not_active IP Right Cessation
- 2004-11-01 DE DE602004016022T patent/DE602004016022D1/en active Active
- 2004-11-01 JP JP2006538420A patent/JP2007519767A/en active Pending
- 2004-11-01 WO PCT/US2004/036372 patent/WO2005042040A1/en active Application Filing
- 2004-11-01 AU AU2004285579A patent/AU2004285579B2/en not_active Ceased
-
2013
- 2013-03-11 US US13/792,478 patent/US20130189334A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050013759A1 (en) * | 1996-08-14 | 2005-01-20 | Grow Ann E. | Practical method for preparing inorganic nanophase materials |
US8088485B2 (en) * | 2002-11-26 | 2012-01-03 | Honda Motor Co., Ltd. | Method for synthesis of metal nanoparticles |
Non-Patent Citations (1)
Title |
---|
Michalik et al, Small Silver Clusters in Smectite Clay Interlayers, J. Phys. Chem, 1996, 100, pp 4213-4218. * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9624973B2 (en) * | 2012-03-19 | 2017-04-18 | Samsung Electronics Co., Ltd. | Apparatus having friction preventing function and method of manufacturing the same |
WO2020065540A1 (en) * | 2018-09-25 | 2020-04-02 | Church & Dwight Co., Inc. | Animal litters exhibiting enhanced odor reduction properties, and related methods |
US11337421B2 (en) * | 2019-12-24 | 2022-05-24 | Hamed Ahari | Method for producing antimicrobial nanofilms packaging cover based on Titanium nano-dioxide through extrusion for extension of food shelf-life |
Also Published As
Publication number | Publication date |
---|---|
CN1925879A (en) | 2007-03-07 |
CN1925880A (en) | 2007-03-07 |
AU2004285579B2 (en) | 2011-02-10 |
AU2004285578B2 (en) | 2010-10-07 |
US20050115462A1 (en) | 2005-06-02 |
DE602004015134D1 (en) | 2008-08-28 |
CN100594944C (en) | 2010-03-24 |
US20050175649A1 (en) | 2005-08-11 |
EP1677843A1 (en) | 2006-07-12 |
AU2004285579A1 (en) | 2005-05-12 |
WO2005042041A1 (en) | 2005-05-12 |
BRPI0415633A (en) | 2006-12-12 |
BRPI0416114A (en) | 2007-01-02 |
EP1677843B1 (en) | 2008-08-20 |
CA2544119C (en) | 2012-05-29 |
ATE401100T1 (en) | 2008-08-15 |
CN1925879B (en) | 2011-07-13 |
WO2005042040A1 (en) | 2005-05-12 |
EP1682193B1 (en) | 2008-07-16 |
ATE405300T1 (en) | 2008-09-15 |
EP1682193A1 (en) | 2006-07-26 |
AU2004285578A1 (en) | 2005-05-12 |
DE602004016022D1 (en) | 2008-10-02 |
ES2311879T3 (en) | 2009-02-16 |
US7988779B2 (en) | 2011-08-02 |
BRPI0415633B1 (en) | 2014-03-04 |
JP2007519615A (en) | 2007-07-19 |
JP2007519767A (en) | 2007-07-19 |
CA2544119A1 (en) | 2005-05-12 |
CA2544109C (en) | 2012-05-29 |
CA2544109A1 (en) | 2005-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2004285579B2 (en) | Composite materials comprising metal-loaded nanoparticles | |
AU2005337071B2 (en) | Absorbent article comprising a thin film including an active agent | |
Lvov et al. | Functional polymer–clay nanotube composites with sustained release of chemical agents | |
EP2480499B1 (en) | Biocidal colloidal dispersions of silica particles with silver ions adsorbed thereon | |
US9192625B1 (en) | Antimicrobial nanocomposite compositions, fibers and films | |
JPS6323960A (en) | High molecular material containing amorphous aluminosilicate particle and production thereof | |
EP2083796B1 (en) | Metal coated nanoparticles for use in the treatment of enzymatic dermatitis | |
MXPA06004819A (en) | Composite materials comprising metal-loaded nanoparticles | |
Topalić-Trivunović et al. | Antibacterial finishing of textile materials using modified bentonite | |
JP2648282B2 (en) | Fungicide for MRSA | |
MXPA06004821A (en) | Absorbent articles comprising metal-loaded nanoparticles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |